<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Heated tobacco products for smoking cessation and reducing smoking prevalence - Tattan-Birch, H - 2022 | Cochrane Library</title> <meta content="Heated tobacco products for smoking cessation and reducing smoking prevalence - Tattan-Birch, H - 2022 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013790.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Heated tobacco products for smoking cessation and reducing smoking prevalence - Tattan-Birch, H - 2022 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013790.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD013790.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Heated tobacco products for smoking cessation and reducing smoking prevalence" name="citation_title"/> <meta content="Harry Tattan-Birch" name="citation_author"/> <meta content="University College London" name="citation_author_institution"/> <meta content="Jamie Hartmann-Boyce" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="Loren Kock" name="citation_author"/> <meta content="University College London" name="citation_author_institution"/> <meta content="Erikas Simonavicius" name="citation_author"/> <meta content="King's College London" name="citation_author_institution"/> <meta content="Leonie Brose" name="citation_author"/> <meta content="King's College London" name="citation_author_institution"/> <meta content="Sarah Jackson" name="citation_author"/> <meta content="University College London" name="citation_author_institution"/> <meta content="Lion Shahab" name="citation_author"/> <meta content="University College London" name="citation_author_institution"/> <meta content="Jamie Brown" name="citation_author"/> <meta content="University College London" name="citation_author_institution"/> <meta content="jamie.brown@ucl.ac.uk" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="1" name="citation_issue"/> <meta content="10.1002/14651858.CD013790.pub2" name="citation_doi"/> <meta content="2022" name="citation_date"/> <meta content="2022/01/06" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013790.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013790.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013790.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Prevalence; Smoking; *Smoking Cessation; *Tobacco Products; Tobacco Use Cessation Devices" name="citation_keywords"/> <meta content="" name="citation_fulltext_world_readable"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013790.pub2&amp;doi=10.1002/14651858.CD013790.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013790.pub2&amp;doi=10.1002/14651858.CD013790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013790.pub2&amp;doi=10.1002/14651858.CD013790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013790.pub2&amp;doi=10.1002/14651858.CD013790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013790.pub2&amp;doi=10.1002/14651858.CD013790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013790.pub2&amp;doi=10.1002/14651858.CD013790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013790.pub2&amp;doi=10.1002/14651858.CD013790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013790.pub2&amp;doi=10.1002/14651858.CD013790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013790.pub2&amp;doi=10.1002/14651858.CD013790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013790.pub2&amp;doi=10.1002/14651858.CD013790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013790.pub2&amp;doi=10.1002/14651858.CD013790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013790.pub2&amp;doi=10.1002/14651858.CD013790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013790.pub2&amp;doi=10.1002/14651858.CD013790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013790.pub2&amp;doi=10.1002/14651858.CD013790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013790.pub2&amp;doi=10.1002/14651858.CD013790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013790.pub2&amp;doi=10.1002/14651858.CD013790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013790.pub2&amp;doi=10.1002/14651858.CD013790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013790.pub2&amp;doi=10.1002/14651858.CD013790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013790.pub2&amp;doi=10.1002/14651858.CD013790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013790.pub2&amp;doi=10.1002/14651858.CD013790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013790.pub2&amp;doi=10.1002/14651858.CD013790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013790.pub2&amp;doi=10.1002/14651858.CD013790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013790.pub2&amp;doi=10.1002/14651858.CD013790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="EBp84H4P";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD013790\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD013790\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013790\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013790\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","de","zh_HANT","th","ms","ja","hr","fa","fr","pl"],languageCode:"en",accessStatus:"open-access",doi:"10.1002/14651858.CD013790.pub2",title:"Heated tobacco products for smoking cessation and reducing smoking prevalence",firstPublishedDate:"Jan 6, 2022 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Tobacco Addiction Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=EBp84H4P&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013790.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013790.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD013790.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD013790.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013790.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD013790.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD013790.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD013790.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD013790.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD013790.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>16997 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD013790.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013790.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013790.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013790.pub2/full#CD013790-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013790.pub2/full#CD013790-sec-0108"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013790.pub2/full#CD013790-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013790.pub2/full#CD013790-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013790.pub2/full#CD013790-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013790.pub2/full#CD013790-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013790.pub2/full#CD013790-sec-0060"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013790.pub2/full#CD013790-sec-0099"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013790.pub2/appendices#CD013790-sec-0113"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/table_n/CD013790StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/table_n/CD013790StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013790.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013790.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013790.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013790.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013790.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD013790.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2022 The Authors. Cochrane Database of Systematic Reviews published by John Wiley &amp; Sons, Ltd. on behalf of The Cochrane Collaboration." data-creative-commons="true" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Heated tobacco products for smoking cessation and reducing smoking prevalence</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013790.pub2/information#CD013790-cr-0004">Harry Tattan-Birch</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013790.pub2/information#CD013790-cr-0005">Jamie Hartmann-Boyce</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013790.pub2/information#CD013790-cr-0006">Loren Kock</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013790.pub2/information#CD013790-cr-0007">Erikas Simonavicius</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013790.pub2/information#CD013790-cr-0008">Leonie Brose</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013790.pub2/information#CD013790-cr-0009">Sarah Jackson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013790.pub2/information#CD013790-cr-0010">Lion Shahab</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013790.pub2/information#CD013790-cr-0011"><i class="icon corresponding-author fa fa-envelope"></i>Jamie Brown</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/information/en#CD013790-sec-0121">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 06 January 2022 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD013790.pub2">https://doi.org/10.1002/14651858.CD013790.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD013790-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013790-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013790-abs-0017">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013790-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013790-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD013790-abs-0007">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013790-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD013790-abs-0001" lang="en"> <section id="CD013790-sec-0001"> <h3 class="title" id="CD013790-sec-0001">Background</h3> <p>Heated tobacco products (HTPs) are designed to heat tobacco to a high enough temperature to release aerosol, without burning it or producing smoke. They differ from e‐cigarettes because they heat tobacco leaf/sheet rather than a liquid. Companies who make HTPs claim they produce fewer harmful chemicals than conventional cigarettes. Some people report stopping smoking cigarettes entirely by switching to using HTPs, so clinicians need to know whether they are effective for this purpose and relatively safe. Also, to regulate HTPs appropriately, policymakers should understand their impact on health and on cigarette smoking prevalence. </p> </section> <section id="CD013790-sec-0002"> <h3 class="title" id="CD013790-sec-0002">Objectives</h3> <p>To evaluate the effectiveness and safety of HTPs for smoking cessation and the impact of HTPs on smoking prevalence.  </p> </section> <section id="CD013790-sec-0003"> <h3 class="title" id="CD013790-sec-0003">Search methods</h3> <p>We searched the Cochrane Tobacco Addiction Group's Specialised Register, CENTRAL, MEDLINE, and six other databases for relevant records to January 2021, together with reference‐checking and contact with study authors and relevant groups. </p> </section> <section id="CD013790-sec-0004"> <h3 class="title" id="CD013790-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) in which people who smoked cigarettes were randomised to switch to exclusive HTP use or a control condition. Eligible outcomes were smoking cessation, adverse events, and selected biomarkers.  RCTs conducted in clinic or in an ambulatory setting were deemed eligible when assessing safety, including those randomising participants to exclusively use HTPs, smoke cigarettes, or attempt abstinence from all tobacco. Time‐series studies were also eligible for inclusion if they examined the population‐level impact of heated tobacco on smoking prevalence or cigarette sales as an indirect measure. </p> </section> <section id="CD013790-sec-0005"> <h3 class="title" id="CD013790-sec-0005">Data collection and analysis</h3> <p>We followed standard Cochrane methods for screening and data extraction. Our primary outcome measures were abstinence from smoking at the longest follow‐up point available, adverse events, serious adverse events, and changes in smoking prevalence or cigarette sales. Other outcomes included biomarkers of harm and exposure to toxicants/carcinogens (e.g. NNAL and carboxyhaemoglobin (COHb)). We used a random‐effects Mantel‐Haenszel model to calculate risk ratios (RR) with 95% confidence intervals (CIs) for dichotomous outcomes. For continuous outcomes, we calculated mean differences on the log‐transformed scale (LMD) with 95% CIs. We pooled data across studies using meta‐analysis where possible. </p> </section> <section id="CD013790-sec-0006"> <h3 class="title" id="CD013790-sec-0006">Main results</h3> <p>We included 13 completed studies, of which 11 were RCTs assessing safety (2666 participants) and two were time‐series studies. We judged eight RCTs to be at unclear risk of bias and three at high risk. All RCTs were funded by tobacco companies. Median length of follow‐up was 13 weeks. </p> <p>No studies reported smoking cessation outcomes. </p> <p>There was insufficient evidence for a difference in risk of adverse events between smokers randomised to switch to heated tobacco or continue smoking cigarettes, limited by imprecision and risk of bias (RR 1.03, 95% CI 0.92 to 1.15; I<sup>2</sup> = 0%; 6 studies, 1713 participants). There was insufficient evidence to determine whether risk of serious adverse events differed between groups due to very serious imprecision and risk of bias (RR 0.79, 95% CI 0.33 to 1.94; I<sup>2</sup> = 0%; 4 studies, 1472 participants). There was moderate‐certainty evidence for lower NNAL and COHb at follow‐up in heated tobacco than cigarette smoking groups, limited by risk of bias (NNAL: LMD −0.81, 95% CI −1.07 to −0.55; I<sup>2</sup> = 92%; 10 studies, 1959 participants; COHb: LMD −0.74, 95% CI −0.92 to −0.52; I<sup>2</sup> = 96%; 9 studies, 1807 participants). Evidence for additional biomarkers of exposure are reported in the main body of the review. </p> <p>There was insufficient evidence for a difference in risk of adverse events in smokers randomised to switch to heated tobacco or attempt abstinence from all tobacco, limited by risk of bias and imprecision (RR 1.12, 95% CI 0.86 to 1.46; I<sup>2</sup> = 0%; 2 studies, 237 participants). Five studies reported that no serious adverse events occurred in either group (533 participants). There was moderate‐certainty evidence, limited by risk of bias, that urine concentrations of NNAL at follow‐up were higher in the heated tobacco use compared with abstinence group (LMD 0.50, 95% CI 0.34 to 0.66; I<sup>2</sup> = 0%; 5 studies, 382 participants). In addition, there was very low‐certainty evidence, limited by risk of bias, inconsistency, and imprecision, for higher COHb in the heated tobacco use compared with abstinence group for intention‐to‐treat analyses (LMD 0.69, 95% CI 0.07 to 1.31; 3 studies, 212 participants), but lower COHb in per‐protocol analyses (LMD −0.32, 95% CI −1.04 to 0.39; 2 studies, 170 participants). Evidence concerning additional biomarkers is reported in the main body of the review. </p> <p>Data from two time‐series studies showed that the rate of decline in cigarette sales accelerated following the introduction of heated tobacco to market in Japan. This evidence was of very low‐certainty as there was risk of bias, including possible confounding, and cigarette sales are an indirect measure of smoking prevalence. </p> </section> <section id="CD013790-sec-0007"> <h3 class="title" id="CD013790-sec-0007">Authors' conclusions</h3> <p>No studies reported on cigarette smoking cessation, so the effectiveness of heated tobacco for this purpose remains uncertain. There was insufficient evidence for differences in risk of adverse or serious adverse events between people randomised to switch to heated tobacco, smoke cigarettes, or attempt tobacco abstinence in the short‐term. There was moderate‐certainty evidence that heated tobacco users have lower exposure to toxicants/carcinogens than cigarette smokers and very low‐ to moderate‐certainty evidence of higher exposure than those attempting abstinence from  all tobacco. Independently funded research on the effectiveness and safety of HTPs is needed.  </p> <p>The rate of decline in cigarette sales accelerated after the introduction of heated tobacco to market in Japan but, as data were observational, it is possible other factors caused these changes. Moreover, falls in cigarette sales may not translate to declining smoking prevalence, and changes in Japan may not generalise elsewhere. To clarify the impact of rising heated tobacco use on smoking prevalence, there is a need for time‐series studies that examine this association. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD013790-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013790-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD013790-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD013790-abs-0018">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013790-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013790-abs-0015">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD013790-abs-0011">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD013790-abs-0010">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD013790-abs-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD013790-abs-0016">Polski</a> </li> <li class="section-language"> <a class="" href="full/th#CD013790-abs-0008">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013790-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD013790-abs-0006">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD013790-abs-0002" lang="en"> <h3>Do heated tobacco products help people to quit smoking, are they safe for this purpose, and have they led to falls in smoking rates? </h3> <p><b>Key messages</b> </p> <p>Heated tobacco probably exposes people to fewer toxins than cigarettes, but possibly more than not using any tobacco. Falls in cigarette sales appeared to speed up following the launch of heated tobacco in Japan, but we are uncertain whether this is caused by people switching from cigarettes to heated tobacco. </p> <p>We need more independently funded research into whether heated tobacco helps people stop smoking, whether it results in unwanted effects, and the impact of rising heated tobacco use on smoking rates.  </p> <p><b>What are heated tobacco products? </b> </p> <p>Heated tobacco products are designed to heat tobacco to a high enough temperature to release vapour, without burning it or producing smoke. They differ from e‐cigarettes because they heat tobacco leaf/sheet rather than a liquid. Many of the harmful chemicals in cigarette smoke are created by burning tobacco. So heating not burning tobacco could reduce the amount of chemicals a user ingests. Some people report stopping smoking cigarettes entirely by switching to using heated tobacco. </p> <p><b>Why we did this Cochrane Review </b> </p> <p>Because cigarette smoking is addictive, many people find it difficult to stop despite the harm it causes. We aimed to find out whether trying to switch to heated tobacco helps people stop smoking cigarettes, and whether it results in unwanted effects. We also wanted to find out whether rising heated tobacco use has affected smoking rates or cigarette sales. </p> <p><b>What did we do?</b> </p> <p>We looked for studies that reported on the use of heated tobacco for stopping smoking, and on unwanted effects and toxin exposure in people asked to use heated tobacco. Here we only included randomised controlled trials, where treatments were given to people at random. This type of study is considered the most reliable way of determining if a treatment works. Finally, we searched for studies looking at changes in smoking rates and cigarette sales following the launch of heated tobacco to market. We included studies published up to January 2021. </p> <p><b>What we found</b> </p> <p>Our search found 13 relevant studies. No studies reported whether heated tobacco helps people stop smoking cigarettes. Eleven trials, all funded by tobacco companies and with 2666 adult smokers, compared unwanted effects and toxin levels in people randomly assigned to use heated tobacco or to continue smoking cigarettes or abstain from tobacco use. </p> <p>Two studies looked at how trends in cigarette sales changed following the launch of heated tobacco in Japan. </p> <p><b>What are the results of our review? </b> </p> <p>We do not know whether using heated tobacco helps people to stop smoking cigarettes (no studies measured this). </p> <p>We are uncertain whether the chances of getting unwanted symptoms from being asked to use heated tobacco are different compared with cigarettes (6 studies, 1713 participants) or no tobacco (2 studies, 237 participants). Serious unwanted symptoms in the short time period studied (average 13 weeks) were rare in all groups, which means we are uncertain about any differences. Toxin levels were probably lower in people using heated tobacco than those smoking cigarettes (10 studies, 1959 participants), but may be higher than in people not using any tobacco products (5 studies, 382 participants). </p> <p>The launch of heated tobacco products in Japan may have caused the decline in cigarette sales to speed up over time (two studies), but it is unclear whether the fall in the percentage of people who smoke also sped up because no studies looked at this.  </p> <p><b>How reliable are these results?</b> </p> <p>Results are based on data from a small number of studies, most of which were funded by tobacco companies.  </p> <p>Results on unwanted effects are likely to change as more evidence becomes available. However, we are moderately confident that levels of measured toxins are lower in people using heated tobacco than smoking cigarettes, but less confident that levels were higher than in people not using any tobacco. We are also less confident that the launch of heated tobacco caused the fall in cigarette sales to speed up, as results came from a single country. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD013790-sec-0108" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD013790-sec-0108"></div> <h3 class="title" id="CD013790-sec-0109">Implications for practice</h3> <section id="CD013790-sec-0109"> <p>No studies reported on the use of heated tobacco for cigarette smoking cessation, so their effectiveness for this purpose remains uncertain.  There was insufficient evidence for differences in risk of adverse or serious adverse events between people randomised to use heated tobacco products (HTPs) or to smoke cigarettes, attempt abstinence, or use snus, but participants only used these for a very short time. However, there was moderate‐certainty evidence that users of heated tobacco have lower exposure to selected toxicants and carcinogens than cigarette smokers, and very low‐ to moderate‐certainty evidence of higher exposure than those attempting abstinence from all tobacco.  </p> <p>The rate of decline in cigarette sales accelerated after the introduction of heated tobacco to market in Japan but, as data were observational, it is possible other factors caused these changes. Moreover, falls in cigarette sales may not translate to declines in smoking prevalence, and changes in Japan may not generalise elsewhere.  </p> </section> <h3 class="title" id="CD013790-sec-0110">Implications for research</h3> <section id="CD013790-sec-0110"> <p>Studies from independent sources are needed that attempt to replicate the randomised controlled trials (RCTs) on safety included in this review — all of which were funded by tobacco companies. Users are likely to continue using HTPs for a prolonged period, so studies should allow for this and build in long‐term follow‐up. Studies are also needed to determine how rates of adverse and serious adverse events differ between those randomised to use heated tobacco, continue smoking cigarettes, or use another treatment. Ideally, studies that measure serious adverse events should be powered on this outcome, which is relatively rare, but of key clinical and policy importance. Further studies should measure how biomarkers of exposure and harm differ across groups, especially for new devices. In the longer‐term, large cohort studies and RCTs are needed to examine how long‐term switching from smoking to heated tobacco affects disease incidence and death. If HTPs are determined to be substantially less harmful than traditional cigarettes, RCTs will be needed into their use for cigarette smoking cessation, preferably following up participants for at least six months. </p> <p>Our literature searches only found population‐level studies examining cigarette sales rather than smoking prevalence. Future research is needed to determine whether the increased rate of decline in cigarette sales following the launch of heated tobacco in Japan translated to similar changes in smoking prevalence trends. Furthermore, to assess whether results generalise, studies need to be conducted in other countries that have also seen substantial growth in heated tobacco use.  </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD013790-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD013790-sec-0008"></div> <div class="table" id="CD013790-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Heated tobacco use compared with cigarette smoking</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Heated tobacco use compared with cigarette smoking</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people who smoke<br/><b>Setting:</b> USA, Japan, UK, South Korea, Poland<br/><b>Intervention:</b> heated tobacco use<br/><b>Comparison:</b> cigarette smoking </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with cigarette smoking</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with heated tobacco use</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events</b> – measured by self‐report </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.03</b><br/>(0.92 to 1.15) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1713<br/>(6 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>235 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>242 per 1000<br/>(216 to 270) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Serious adverse events</b> – measured by self‐report and medical records </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.79</b><br/>(0.33 to 1.94) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2009<br/>(9 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>13 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>10 per 1000<br/>(4 to 24) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>NNAL</b><br/>at follow‐up – measured in urine </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>LMD 0.81</b> lower<br/>(1.07 lower to 0.55 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1959<br/>(10 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>LMD has no units as it is calculated from the logarithm of biomarker measurements.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>COHb</b><br/>at follow‐up – measured in blood </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>LMD 0.74</b> lower<br/>(0.92 lower to 0.52 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1807<br/>(9 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>LMD has no units as it is calculated from the logarithm of biomarker measurements.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>COHb:</b> carboxyhaemoglobin; <b>LMD:</b> difference in means of log‐transformed measurements; <b>NNAL:</b> 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanol; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for risk of bias: all studies were at either unclear or high risk of bias.<br/><sup>b</sup>Downgraded one level for imprecision: confidence intervals contain clinically meaningful benefit and clinically meaningful harm.<br/><sup>c</sup>Downgraded two levels for imprecision: confidence intervals contain large clinically meaningful benefit and clinically meaningful harm. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD013790-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Heated tobacco use compared with abstinence from tobacco</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Heated tobacco use compared with abstinence from tobacco</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people who smoke<br/><b>Setting:</b> USA, Japan, UK, South Korea<br/><b>Intervention:</b> heated tobacco use<br/><b>Comparison:</b> abstinence from tobacco </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with abstinence from tobacco</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with heated tobacco use</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Smoking cessation</b> – not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events</b> – measured by self‐report </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.12</b><br/>(0.86 to 1.46) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>237<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>468 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>525 per 1000<br/>(403 to 684) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Serious adverse events</b> – measured by self‐report and medical records </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>533<br/>(5 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>c,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No serious adverse events were reported.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>NNAL</b><br/>at follow‐up – measured in urine </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>LMD 0.50</b> higher<br/>(0.34 higher to 0.66 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>382<br/>(5 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>LMD has no units as it is calculated from the logarithm of biomarker measurements.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>COHb</b> at follow‐up – measured in blood </p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p><b>LMD 0.69 higher</b> (0.07 higher to 1.31 higher) for analyses using intention‐to‐treat, but LMD 0.32 lower (1.04 lower to 0.39 higher) for per‐protocol analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>212<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,d,e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reported narratively due to inconsistency of results across subgroups.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>COHb:</b> carboxyhaemoglobin; <b>LMD:</b> difference in means of log‐transformed measurements; <b>NNAL:</b> 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanol; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for imprecision: confidence intervals contained clinically meaningful benefit and clinically meaningful harm.<br/><sup>b</sup>Downgraded two levels for risk of bias: all studies were considered at high risk of bias.<br/><sup>c</sup>Downgraded two levels for imprecision: no serious adverse events occurred so confidence intervals could not be calculated.<br/><sup>d</sup>Downgraded one level for risk of bias: two of the five studies were considered high risk of bias, while three had uncertain risk of bias.<br/><sup>e</sup>Downgraded two levels for inconsistency: there was unexplained heterogeneity and results were inconsistent across subgroups and sensitivity analyses. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD013790-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Heated tobacco use compared with snus use</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Heated tobacco use compared with snus use</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people who smoke<br/><b>Setting:</b> USA<br/><b>Intervention:</b> heated tobacco use<br/><b>Comparison:</b> snus use </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with snus use</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with heated tobacco use</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Smoking cessation</b> – not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events</b> – measured by self‐report  </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.30</b><br/>(0.94 to 1.80) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>87<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>558 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>726 per 1000<br/>(525 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Serious adverse events</b> – measured by self‐report and medical records </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>44<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No serious adverse events were reported.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>NNAL</b> at follow‐up – measured in urine </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 160 ng/24 hours lower</b><br/>(339 lower to 19 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>COHb</b> at follow‐up – measured in blood </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>6.0% saturation</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3.75% saturation  (2.5% higher to 5.0% higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 2.24% saturation higher</b><br/>(0.69 higher to 3.79 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>COHb:</b> carboxyhaemoglobin; <b>MD:</b> mean difference; <b>NNAL:</b> 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanol; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels for indirectness: participants in the included study were given carbon‐tip heated tobacco products, which are unlike heated tobacco products currently on the market.<br/><sup>b</sup>Downgraded one levels for imprecision: confidence intervals incorporate no clinically meaningful difference.<br/><sup>c</sup>Downgraded two levels for imprecision: no serious adverse events occurred so confidence intervals could not be calculated. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD013790-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Population‐level impact of heated tobacco on cigarette smoking prevalence</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Population‐level impact of heated tobacco on cigarette smoking prevalence</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Patient or population:</b> N/A<br/><b>Setting:</b> Japan<br/><b>Intervention:</b> introduction of heated tobacco to market<br/><b>Comparison:</b> N/A </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Impact</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cigarette sales</b> – assessed with national and regional sales data </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 study found that the yearly percentage decline in cigarette sales accelerated after the introduction of heated tobacco in Japan, increasing from a mean decline of −3.10% across 2011–2015 to −16.38% across 2016–2019. A second study found similar results using a different method; it found that per capita cigarette sales were increasing at a rate of 0.10 to 0.14 (depending on statistical approach) per month before the introduction of heated tobacco in Japan. After the introduction, they declined at a rate of 0.63 to 0.66 cigarettes per month. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>N/A (2 observational studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>N/A: not applicable/available.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for indirectness: cigarette sales do not necessarily translate to reductions in smoking prevalence, as smokers may reduce the amount they smoke rather than stop smoking entirely.<br/><sup>b</sup>Downgraded one level for risk of bias: one study was considered to be at serious risk of bias, while the other was deemed at moderate risk. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD013790-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD013790-sec-0009"></div> <section id="CD013790-sec-0010"> <h3 class="title" id="CD013790-sec-0010">Description of the condition</h3> <p>Tobacco use kills eight million people each year, making it one of the leading preventable causes of death worldwide (<a href="./references#CD013790-bbs2-0045" title="GBD 2019 Tobacco Collaborators.Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet2021;397(10292):2337-60. [DOI: 10.1016/S0140-6736(21)01169-7]">GBD 2021</a>). Approximately 90% of these deaths result from the most harmful form of tobacco consumption: smoking (<a href="./references#CD013790-bbs2-0037" title="DropeJ , SchlugerN , CahnZ , DropeJ , HamillS , IslamiF , et al.The Tobacco Atlas. 6 edition. Atlanta (GA): American Cancer Society and Vital Strategies, 2018.">Drope 2018</a>). Therefore, reducing smoking prevalence is one of the most effective ways of improving population health (<a href="./references#CD013790-bbs2-0060" title="HolfordT , MezaR , WarnerK , MeernikCE , JeonJM , SureshH , et al.Tobacco control and the reduction in smoking-related premature deaths in the United States, 1964–2012. JAMA2014;311(2):164-71.">Holford 2014</a>). </p> <p>Although most smokers want to quit, smoking is highly addictive. Most people who make a serious attempt to quit fail, with only 3% to 10% still abstinent after one year (<a href="./references#CD013790-bbs2-0061" title="HughesJR , KeelyJ , NaudS .Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction2004;99(1):29-38. [DOI: 10.1111/j.1360-0443.2004.00540.x]">Hughes 2004</a>; <a href="./references#CD013790-bbs2-0063" title="JacksonSE , McGowanJA , UbhiHK , ProudfootH , ShahabL , BrownJ , et al.Modelling continuous abstinence rates over time from clinical trials of pharmacological interventions for smoking cessation. Addiction2019;114(5):787-97. [DOI: 10.1111/add.14549]">Jackson 2019a</a>). Available treatments such as behavioural support, varenicline, and nicotine replacement therapy (NRT) improve the chance that these attempts will succeed (<a href="./references#CD013790-bbs2-0033" title="CahillK , Lindson-HawleyN , ThomasKH , FanshaweTR , LancasterT .Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews2016, Issue 5. Art. No: CD006103. [DOI: 10.1002/14651858.CD006103.pub7]">Cahill 2016</a>; <a href="./references#CD013790-bbs2-0052" title="Hartmann-BoyceJ , ChepkinSC , YeW , BullenC , LancasterT .Nicotine replacement therapy versus control for smoking cessation. Cochrane Database of Systematic Reviews2018, Issue 5. Art. No: CD000146. [DOI: 10.1002/14651858.CD000146.pub5]">Hartmann‐Boyce 2018</a>; <a href="./references#CD013790-bbs2-0053" title="Hartmann-BoyceJ , HongB , Livingstone-BanksJ , WheatH , FanshaweTR .Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation. Cochrane Database of Systematic Reviews2019, Issue 6. Art. No: CD009670. [DOI: 10.1002/14651858.CD009670.pub4]">Hartmann‐Boyce 2019</a>; <a href="./references#CD013790-bbs2-0054" title="Hartmann-BoyceJ , Livingstone-BanksJ , Ordóñez-MenaJM , FanshaweTR , LindsonN , FreemanSC , et al.Behavioural interventions for smoking cessation: an overview and network meta‐analysis. Cochrane Database of Systematic Reviews2021, Issue 1. Art. No: CD013229. [DOI: 10.1002/14651858.CD013229.pub2]">Hartmann‐Boyce 2021a</a>). However, even with these treatments, success rates are typically under 25%, and many who try to quit do not use any support (<a href="./references#CD013790-bbs2-0032" title="BorlandR , LiL , DriezenP , WilsonN , HammondD , ThompsonME , et al.Cessation assistance reported by smokers in 15 countries participating in the International Tobacco Control (ITC) policy evaluation surveys. Addiction2012;107(1):197-205. [DOI: 10.1111/j.1360-0443.2011.03636.x]">Borland 2012</a>; <a href="./references#CD013790-bbs2-0064" title="JacksonSE , KotzD , WestR , BrownJ .Moderators of real-world effectiveness of smoking cessation aids: a population study. Addiction2019;114(9):1627-38. [DOI: 10.1111/add.14656]">Jackson 2019b</a>). There remains an urgent need to identify new, effective, and safer alternatives to cigarettes to reduce smoking prevalence. </p> </section> <section id="CD013790-sec-0011"> <h3 class="title" id="CD013790-sec-0011">Description of the intervention</h3> <p>Heated (or heat‐not‐burn) tobacco products (HTPs) are designed to heat tobacco leaf/sheet to a high enough temperature to release nicotine‐infused aerosol, without burning it or producing smoke. Many of the toxic and carcinogenic products of cigarette smoking are formed during combustion. HTPs are marketed as less harmful and as alternatives to conventional cigarettes because they are engineered to avoid combustion (<a href="./references#CD013790-bbs2-0069" title="MathersA , SchwartzR , O'ConnorS , FungM , DiemertL .Marketing IQOS in a dark market. Tobacco Control2017;28:237-8. [DOI: 10.1136/tobaccocontrol-2017-054216]">Mathers 2017</a>).  The extent to which they help people quit smoking is largely unknown, and their impact on youth uptake to smoking is contentious (<a href="./references#CD013790-bbs2-0036" title="CzoliCD , WhiteCM , ReidJL , O'connorRJ , HammondD .Awareness and interest in IQOS heated tobacco products among youth in Canada, England and the USA. Tobacco Control2020;29(1):89-95. [DOI: 10.1136/tobaccocontrol-2018-054654]">Czoli 2020</a>). Therefore, it is unclear what impact HTPs will have on smoking prevalence across the population. </p> <p>'Premier' was the first HTP made available for consumers. It resembled a cigarette, but the tobacco was not directly burned, instead it was heated by lighting a carbon‐tip (i.e. not electronic). Premier was introduced to test markets throughout the US by RJ Reynolds in 1988, but it was not widely used and was discontinued in 1989 (<a href="./references#CD013790-bbs2-0082" title="StapletonJA , RussellMA , SutherlandG , FeyerabendC .Nicotine availability from Eclipse tobacco-heating cigarette. Psychopharmacology1998;139:288-90. [DOI: doi.org/10.1007/s002130050719]">Stapleton 1998</a>). In the early 2000s, RJ Reyolds introduced another carbon‐tip HTP, 'Eclipse', and they funded research to support marketing claims that it reduced health risks relative to cigarettes. A court case in the US succeeded in challenging these reduced risk claims, but trial evidence did suggest users of Eclipse had lower exposure to toxicants than people smoking cigarettes (<a href="./references#CD013790-bbs2-0028" title="AndersonSJ , LingPM .&quot;And they told two friends…and so on&quot;: RJ Reynolds' viral marketing of Eclipse and its potential to mislead the public. Tobacco Control2008;17(4):222-9. [DOI: 10.1136/tc.2007.024273]">Anderson 2008</a>; <a href="./references#CD013790-bbs2-0075" title="RennardSI , UminoT , MillatmalT , DaughtonD , ManouilovaLS , UllrichFA , et al.Evaluation of subclinical respiratory tract inflammation in heavy smokers who switch to a cigarette-like nicotine delivery device that primarily heats tobacco. Nicotine &amp; Tobacco Research2002;4(4):467-76. [DOI: 10.1080/1462220021000018407]">Rennard 2002</a>). The first electronic HTPs were produced by Philip Morris International (PMI). They introduced 'Accord' into the US in 1997 and a similar product, 'Heatbar', in Germany in 2007 (<a href="./references#CD013790-bbs2-0039" title="EliasJ , DutraLM , St HelenG , LingPM .Revolution or redux? Assessing IQOS through a precursor product. Tobacco Control2018;27:s102-10. [DOI: 10.1136/tobaccocontrol-2018-054327]">Elias 2018</a>). While these products have both since been discontinued, they acted as predecessors to 'IQOS'.  </p> <p>The current HTP market is dominated by electronic rather than carbon‐tip devices. Current brands include  IQOS by PMI, 'glo' by British American Tobacco, and 'Ploom Tech' by Japan Tobacco International (<a href="./references#CD013790-bbs2-0089" title="World Health Organization.Heated Tobacco Products (HTPs) Market Monitoring Information. www.who.int/tobacco/publications/prod_regulation/htps-marketing-monitoring/en/ (accessed prior to 21 November 2021).">WHO 2018</a>). IQOS and glo produce aerosol by directly heating tobacco sticks which resemble small cigarettes. Conversely, Ploom Tech produces aerosol by heating a similar liquid to that found in e‐cigarettes. This aerosol is then drawn through a bulb of tobacco to infuse it with flavour. Of these products, IQOS was the first to launch in 2014 in Japan and Italy, and it has since entered markets across Asia, Europe, and the Americas. Most recently, in 2019, the US Food and Drug Administration (FDA) permitted the sale of IQOS (<a href="./references#CD013790-bbs2-0041" title="US Food and Drug Administration.FDA permits sale of IQOS tobacco heating system through premarket tobacco product application pathway. www.fda.gov/news-events/press-announcements/fda-permits-sale-iqos-tobacco-heating-system-through-premarket-tobacco-product-application-pathway (accessed prior to 21 November 2021).">FDA 2019</a>) and in 2020 authorised their marketing as a modified‐exposure tobacco product (<a href="./references#CD013790-bbs2-0042" title="US Food and Drug Administration.FDA authorizes marketing of IQOS tobacco heating system with 'reduced exposure' information. www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-iqos-tobacco-heating-system-reduced-exposure-information (accessed prior to 21 November 2021).">FDA 2020</a>). At the time of writing, HTPs were most popular in Japan and the Republic of Korea; tobacco sticks for HTPs constituted 15.8% and 8.0% respectively of each country's tobacco market in 2018 (<a href="./references#CD013790-bbs2-0089" title="World Health Organization.Heated Tobacco Products (HTPs) Market Monitoring Information. www.who.int/tobacco/publications/prod_regulation/htps-marketing-monitoring/en/ (accessed prior to 21 November 2021).">WHO 2018</a>). Market research by Euromonitor estimates that HTPs had an increased share of the retail value of all nicotine or tobacco products between 2017 and 2018, which was similar to e‐cigarettes globally (<a href="./references#CD013790-bbs2-0040" title="Euromonitor International.Smokeless tobacco, e-vapour products and heated tobacco in world. Euromonitor Passport2020.">Euromonitor 2020</a>). However, HTP use remains rare in North America and much of Europe (<a href="./references#CD013790-bbs2-0044" title="GallusS , LugoA , LuiX , BorroniE , ClancyL , GoriniG .Use and awareness of heated tobacco products in Europe. Journal of Epidemiology 2021 Jan 16 [Epub ahead of print]. [DOI: 10.2188/jea.JE20200248]">Gallus 2021</a>; <a href="./references#CD013790-bbs2-0068" title="LavertyAA , VardavasCI , FilippidisFT .Prevalence and reasons for use of heated tobacco products (HTP) in Europe: an analysis of Eurobarometer data in 28 countries. Lancet Regional Health Europe2021;8:100159. [DOI: 10.1016/j.lanepe.2021.100159]">Laverty 2021</a>; <a href="./references#CD013790-bbs2-0071" title="MillerCR , SutantoE , SmithDM , HitchmanSC , GravelyS , YongHH , et al.Awareness, trial and use of heated tobacco products among adult cigarette smokers and e-cigarette users: findings from the 2018 ITC Four Country Smoking and Vaping Survey. Tobacco Control 2020 Sep 29 [Epub ahead of print]. [DOI: 10.1136/tobaccocontrol-2020-055985]">Miller 2020</a>; <a href="./references#CD013790-bbs2-0084" title="Tattan-BirchH , BrownJ , ShahabL , JacksonSE .Trends in use of e-cigarette device types and heated tobacco products from 2016 to 2020 in England. Scientific Reports2021;11:13203. [DOI: 10.1038/s41598-021-92617-x]">Tattan‐Birch 2021</a>).  </p> </section> <section id="CD013790-sec-0012"> <h3 class="title" id="CD013790-sec-0012">How the intervention might work</h3> <p>Nicotine is the primary addictive compound in cigarettes. Neuroadaptation to repeated nicotine delivery from smoking causes people who quit to experience withdrawal and cravings (<a href="./references#CD013790-bbs2-0031" title="BenowitzN .Nicotine addiction. New England Journal of Medicine2010;362(24):2295-303. [DOI: 10.1056/NEJMra0809890]">Benowitz 2010</a>; <a href="./references#CD013790-bbs2-0088" title="WestR .Tobacco smoking: health impact, prevalence, correlates and interventions. Psychology &amp; Health2017;32(8):1018-36. [DOI: 10.1080/08870446.2017.1325890]">West 2017</a>). Like cigarettes, HTPs contain nicotine. They may aid smoking cessation in a similar way to NRT and e‐cigarettes: people can use them to relieve nicotine cravings without smoking cigarettes (<a href="./references#CD013790-bbs2-0086" title="WadgaveU , NageshL .Nicotine replacement therapy: an overview. International Journal of Health Science2016;32(8):425-35. [DOI: 10.12816/0048737]">Wadgave 2016</a>). HTPs may also provide certain advantages over NRT. One limitation of NRT is that it poorly addresses the behavioural and sensory cues associated with cigarette smoking, such as repeated hand‐to‐mouth actions and the scratch at the back of the throat when inhaling smoke. Evidence shows that denicotinised cigarettes reduce cravings and withdrawal symptoms among abstinent smokers, despite containing negligible levels of nicotine (<a href="./references#CD013790-bbs2-0076" title="RoseJ .Nicotine and nonnicotine factors in cigarette addiction. Psychopharmacology2006;184:274-85. [DOI: 10.1007/s00213-005-0250-x]">Rose 2006</a>). This suggests that these cues contribute to cigarette dependence. HTPs may more closely replicate these cues than NRT. Because HTP aerosol is delivered to the throat and lungs, nicotine absorption likely occurs more rapidly than from patches, gum, or lozenges, which are absorbed through the skin or buccal mucosa (<a href="./references#CD013790-bbs2-0080" title="SimonaviciusE , McNeillA , ShahabL , BroseLS .Heat-not-burn tobacco products: a systematic literature review. Tobacco Control2018;28(5):582-94. [DOI: 10.1136/tobaccocontrol-2018-054419]">Simonavicius 2018</a>). The speed with which nicotine is absorbed may be one of the key determinants of dependence (<a href="./references#CD013790-bbs2-0030" title="BenowitzNL .Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annual Review of Pharmacology and Toxicology2009;49(1):57-71. [DOI: 10.1146/annurev.pharmtox.48.113006.094742]">Benowitz 2009</a>), so HTPs may provide a better replacement for cigarette smoking than NRT. E‐cigarettes also deliver nicotine rapidly to the throat and possibly lungs (<a href="./references#CD013790-bbs2-0051" title="HajekP , PittaccioK , PesolaF , Myers SmithK , Phillips‐WallerA , PrzuljD .Nicotine delivery and users’ reactions to Juul compared with cigarettes and other e-cigarette products. Addiction2020;115(6):1141-8. [DOI: 10.1111/add.14936]">Hajek 2020</a>; <a href="./references#CD013790-bbs2-0087" title="WagenerTL , FloydEL , StepanovI , DriskillLM , FrankSG , MeierE , et al.Have combustible cigarettes met their match? The nicotine delivery profiles and harmful constituent exposures of second-generation and third-generation electronic cigarette users. Tobacco Control2017;26(e1):23-8. [DOI: 10.1136/tobaccocontrol-2016-053041]">Wagener 2017</a>) and, like HTPs, they mimic the hand‐to‐mouth actions of cigarette smoking. But only HTPs contain tobacco leaf/sheet, so their flavour may more closely resemble cigarette smoke (<a href="./references#CD013790-bbs2-0074" title="PoyntonS , SuttonJ , GoodallS , MarghamJ , ForsterM , ScottK , et al.A novel hybrid tobacco product that delivers a tobacco flavour note with vapour aerosol (Part 1): product operation and preliminary aerosol chemistry assessment. Food and Chemical Toxicology2017;106:522-32. [DOI: 10.1016/j.fct.2017.05.022]">Poynton 2017</a>), which may make them more attractive to smokers (<a href="./references#CD013790-bbs2-0085" title="TompkinsCN , BurnleyA , McNeillA , HitchmanSC .Factors that influence smokers' and ex-smokers' use of IQOS: a qualitative study of IQOS users and ex-users in the UK. Tobacco Control2021;30(1):16-23. [DOI: 10.1136/tobaccocontrol-2019-055306]">Tompkins 2021</a>). Moreover, in some countries, the sale of nicotine e‐cigarettes is banned or heavily restricted (<a href="./references#CD013790-bbs2-0038" title="DyerO .India bans e-cigarettes by executive order. BMJ2019;366:i5649. [DOI: doi:10.1136/bmj.l5649]">Dyer 2019</a>). In such environments, HTPs may be the only consumer product available that delivers nicotine rapidly through a potentially less harmful medium than tobacco smoke<i>. </i> </p> <p>We refer to the complete replacement of cigarettes with HTPs as 'switching'. A substantial proportion of people who use HTPs for smoking cessation may continue using these products for some time after they stop smoking cigarettes, as is the case with e‐cigarettes (<a href="./references#CD013790-bbs2-0050" title="HajekP , Phillips-WallerA , PrzuljD , PesolaF , Myers SmithK , BisalN , et al.A randomized trial of e-cigarettes versus nicotine-replacement therapy. New England Journal of Medicine2019;380(7):629-37. [DOI: 10.1056/NEJMoa1808779]">Hajek 2019</a>; <a href="./references#CD013790-bbs2-0081" title="SimonaviciusE , McNeillA , BroseLS .Transitions in smoking and nicotine use from 2016 to 2017 among a UK cohort of adult smokers and ex-smokers. Drug and Alcohol Review2020;39(7):994-1005. [DOI: 10.1111/dar.13063]">Simonavicius 2020</a>). Encouraging people to switch from smoking cigarettes to using HTPs would only be beneficial if HTPs are less harmful to health or if HTPs eventually help people taper off nicotine entirely. The safety of HTPs to users depends on both the acute harm, measured by adverse and serious adverse events, and the long‐term harm of repeated inhalation of damaging compounds in HTP aerosols. </p> <p>Biomarkers can be used to measure exposure to these harmful toxicants and carcinogens. Important exposure biomarkers include: 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanol (NNAL), a marker of tobacco‐specific N‐nitrosamine exposure that is linked to numerous cancers (<a href="./references#CD013790-bbs2-0062" title="IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.Personal habits and indoor combustions: a review of human carcinogens. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans2012. [PMID: 23193840]">IARC 2012</a>); 1‐hydroxypyrene (1‐OHP) and 1‐ and 2‐naphthol, indicators of exposure to polycyclic aromatic hydrocarbons that are associated with cancers and kidney and liver damage; 3‐hydroxypropylmercapturic acid (3‐HPMA), a marker of exposure to acrolein that is linked to respiratory disease (<a href="./references#CD013790-bbs2-0090" title="YeagerP , KushmanM , ChemerynskiS , WeilR , FuX , WhiteM , et al.Proposed mode of action for acrolein respiratory toxicity associated with inhaled tobacco smoke. Toxicological Sciences2016;151(2):347-64. [DOI: 10.1093/toxsci/kfw051]">Yeager 2016</a>); and carboxyhaemoglobin (COHb), a measure of recent carbon monoxide (CO) intake. Details about these and other exposure biomarkers are available in <a href="./appendices#CD013790-sec-0114">Appendix 1</a>. </p> <p>Manufacturers of HTPs claim that the aerosol they produce contains significantly lower levels of toxicants than cigarette smoke and, as a result, that they have reduced risk potential or are less harmful (<a href="./references#CD013790-bbs2-0029" title="British American Tobacco.The science behind glo. www.bat-science.com/groupms/sites/BAT_B9JBW3.nsf/vwPagesWebLive/DOBA2J7K (accessed 15 November 2020).">BAT 2020</a>; <a href="./references#CD013790-bbs2-0073" title="Phillip Morris International.The difference between switching to IQOS and continuing to smoke cigarettes. www.pmiscience.com/discover/news/the-difference-between-switching-to-iqos-and-continuing-to-smoke-cigarettes (accessed prior to 21 November 2021).">PMI 2018</a>). Two systematic reviews supported claims about lower toxicant levels, but found that most research into HTPs was funded through sources affiliated with the tobacco industry (<a href="./references#CD013790-bbs2-0065" title="JankowskiM , BrożekGM , LawsonJ , SkoczyńskiS , MajekP , ZejdaJE .New ideas, old problems? Heated tobacco products – a systematic review. International Journal of Occupational Medicine and Environmental Health2019;32(5):595-634. [DOI: 10.13075/ijomeh.1896.01433]">Jankowski 2019</a>; <a href="./references#CD013790-bbs2-0080" title="SimonaviciusE , McNeillA , ShahabL , BroseLS .Heat-not-burn tobacco products: a systematic literature review. Tobacco Control2018;28(5):582-94. [DOI: 10.1136/tobaccocontrol-2018-054419]">Simonavicius 2018</a>). In addition, reduced exposure does not necessarily indicate reduced harm. The US FDA judged that there was sufficient evidence that IQOS reduced exposure to harmful chemicals (<a href="./references#CD013790-bbs2-0042" title="US Food and Drug Administration.FDA authorizes marketing of IQOS tobacco heating system with 'reduced exposure' information. www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-iqos-tobacco-heating-system-reduced-exposure-information (accessed prior to 21 November 2021).">FDA 2020</a>), but insufficient evidence on whether switching from smoking to HTPs reduces harm, such as pulmonary function or biomarkers linked to smoking‐related harm (<a href="./references#CD013790-bbs2-0046" title="GlantzSA .PMI's own in vivo clinical data on biomarkers of potential harm in Americans show that IQOS is not detectably different from conventional cigarettes. Tobacco Control2018;27:9-12. [DOI: 10.1136/tobaccocontrol-2018-054413]">Glantz 2018</a>; <a href="./references#CD013790-bbs2-0072" title="MoazedF , ChunL , MatthayMA , CalfeeCS , GottsJ .Assessment of industry data on pulmonary and immunosuppressive effects of IQOS. Tobacco Control2018;27:20-5. [DOI: 10.1136/tobaccocontrol-2018-054296]">Moazed 2018</a>). It is also the case that safety, especially of longer‐term use, cannot be addressed with confidence until long‐term cohort studies have collected sufficient data. </p> </section> <section id="CD013790-sec-0013"> <h3 class="title" id="CD013790-sec-0013">Why it is important to do this review</h3> <p>There is substantial variation between countries in their regulatory approaches to HTPs, and within countries across different nicotine products. In order for policymakers to regulate HTPs effectively and proportionately, there is a need for evidence to inform a judgement on their likely public health impact. The net impact of HTPs on public health will depend on a variety of factors. Three influential elements that could result in HTPs benefiting public health are if they increase smoking cessation, decrease smoking prevalence, and are less harmful than cigarette smoking. Conversely, even if these products are shown to be much less harmful than cigarettes, HTPs could damage public health if they hinder smoking cessation or increase smoking prevalence. </p> <p>The effect of HTP use on smoking prevalence will depend on whether they influence rates of attempted quitting among cigarette smokers, the proportion of these attempts that are successful, cigarette uptake among non‐smokers, and relapse among people who had previously quit smoking. Therefore, we are not only interested in studies that report individual‐level effects of HTPs on smoking cessation, but also those that estimate their population‐level effects on smoking prevalence<i>.</i> This review will investigate up‐to‐date evidence for both, using appropriate study designs. </p> <p>The growing popularity of HTPs means that people who smoke may be increasingly likely to seek advice from practitioners who need to know whether HTPs are effective for smoking cessation and how their safety compares with cigarettes and other alternative nicotine products. If HTPs are found to be safe and effective for smoking cessation, they would offer a novel treatment for cigarette addiction. Moreover, evidence on associations between HTP use and smoking prevalence will help to guide the regulation of HTPs. </p> <p>Licensed smoking cessation medications tend to be used for a short time while quitting, whereas people may continue using HTPs for extended periods after they quit. This means that it is especially important to evaluate indicators of the long‐term safety of HTP use (such as exposure to toxicants and carcinogens) in addition to adverse events occurring in the short term. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD013790-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD013790-sec-0014"></div> <p>To evaluate the effectiveness and safety of HTPs for smoking cessation and the impact of HTPs on smoking prevalence. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD013790-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD013790-sec-0015"></div> <section id="CD013790-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD013790-sec-0017"> <h4 class="title">Types of studies</h4> <p>We divided the methods into the three subsections, representing the different objectives of the review: effectiveness for smoking cessation, safety, and smoking prevalence. </p> <section id="CD013790-sec-0018"> <h5 class="title">Effectiveness for smoking cessation</h5> <p>Individual‐level and cluster‐randomised controlled trials (RCTs) to examine the effectiveness (or efficacy) of HTPs for tobacco smoking cessation. </p> </section> <section id="CD013790-sec-0019"> <h5 class="title">Safety</h5> <p>Individual‐level, randomised cross‐over and cluster‐RCTs to explore adverse and serious adverse events and biomarkers of toxicant and carcinogen exposure. RCTs in optimised settings for smoking cessation, such as those where participants stayed in a clinic with restricted access to tobacco products, were eligible for inclusion, as were studies in naturalistic or ambulatory settings.  </p> </section> <section id="CD013790-sec-0020"> <h5 class="title">Smoking prevalence</h5> <p>Interrupted and multiple time‐series studies were included to examine the population‐level effect of HTPs on cigarette smoking prevalence. Smoking cessation interventions may not be representative of the way most people use HTPs, which is without support from a researcher or trained specialist. Moreover, even if HTPs encourage smoking cessation among those trying to quit, their impact on smoking prevalence depends on how they affect smoking initiation and the number of people who make a quit attempt and are successful in remaining abstinent. We used time‐series studies to assess how changes in HTP prevalence are associated with changes in smoking prevalence (or cigarette sales), with the limitation that associations might not reflect causal effects. </p> <p>We included studies regardless of language or status of publication.</p> </section> </section> <section id="CD013790-sec-0021"> <h4 class="title">Types of participants</h4> <section id="CD013790-sec-0022"> <h5 class="title">Effectiveness and safety</h5> <p>We included adults who were defined as current cigarette smokers by the study at the time of enrolment. </p> </section> <section id="CD013790-sec-0023"> <h5 class="title">Smoking prevalence</h5> <p>We did not restrict by participant characteristics, as we are interested in population‐level data. We focused on any individuals who indicated their smoking status or consumption and HTP use or consumption, measured by survey or by record of sales. </p> </section> </section> <section id="CD013790-sec-0024"> <h4 class="title">Types of interventions</h4> <p>HTPs, defined as hand‐held devices that aim to heat tobacco to a temperature high enough to produce a nicotine‐infused aerosol but too low to cause self‐sustaining combustion. HTPs differ from e‐cigarettes in that they heat compressed tobacco leaf rather than a liquid that is infused with nicotine. </p> <section id="CD013790-sec-0025"> <h5 class="title">Effectiveness and safety</h5> <p>We were interested in studies that compared HTPs, or the addition of HTPs, to no treatment (i.e. continued tobacco smoking), placebo or any other smoking cessation treatment, including NRT, e‐cigarettes, snus, varenicline, bupropion, and behavioural support. HTPs could be provided in addition to any other smoking cessation treatment, providing there was equivalent provision of the additional treatment for the control group. We only included studies where participants in the HTP arm were instructed to stop smoking combustible cigarettes for at least seven days.  </p> </section> <section id="CD013790-sec-0026"> <h5 class="title">Smoking prevalence</h5> <p>For interrupted time‐series studies, the interventions of interest were the introduction of HTPs to market or the time point where HTPs began gaining popularity. For multiple time‐series studies, we were interested in the extent to which changes in the prevalence of HTP use were associated with changes in the prevalence of cigarette smoking (or cigarette sales as a proxy), after adjusting for other influences that could affect changes in the prevalence of smoking at the population level.  </p> </section> </section> <section id="CD013790-sec-0027"> <h4 class="title">Types of outcome measures</h4> <section id="CD013790-sec-0028"> <h5 class="title">Primary outcomes</h5> <section id="CD013790-sec-0029"> <h6 class="title">Effectiveness</h6> <p> <ul id="CD013790-list-0001"> <li> <p>Tobacco smoking cessation at the longest follow‐up point available, using intention‐to‐treat and biochemically verified abstinence where possible. While HTPs contain tobacco, they are designed to avoid or minimise combustion and smoke. Therefore, HTP use was not classified as tobacco smoking. If review updates find studies reporting smoking cessation, we will only include those which report abstinence at four‐week follow‐up or longer. We will use the strictest definition of abstinence recorded, that is, prolonged or continuous abstinence over point prevalence, and biochemically verified over self‐reported abstinence. Typically, Cochrane Tobacco Addiction Group reviews only include data on smoking cessation at six months or longer. We will include short‐term outcomes in the next update of this review because we anticipate a paucity of longer‐term data. In subsequent updates, as and when more data become available, we may change the inclusion criteria accordingly. </p> </li> </ul> </p> </section> <section id="CD013790-sec-0030"> <h6 class="title">Safety</h6> <p> <ul id="CD013790-list-0002"> <li> <p>Number of people reporting adverse events and serious adverse events. We defined serious adverse events as medical incidents that are potentially life‐threatening, require hospitalisation, result in disability or death, or a combination of these. Adverse events were medical problems — including cough, headache, and dry mouth — that did not fulfil the above criteria to be considered serious. </p> </li> </ul> </p> </section> <section id="CD013790-sec-0031"> <h6 class="title">Smoking prevalence</h6> <p> <ul id="CD013790-list-0003"> <li> <p>Change in the prevalence of cigarette smoking, measured as the proportion of people in a given locality that regularly smoke cigarettes or other combustible tobacco products, over a defined time period. We included cigarette sales as a proxy for prevalence, measured as the number of cigarettes sold in a given locality over a given time period. This was used as a proxy because, in a population where mean cigarette consumption among smokers remains stable, declines in cigarette sales imply falls in smoking prevalence. However, it should be considered an indirect measure of prevalence because smokers can reduce their cigarette consumption without quitting. </p> </li> </ul> </p> </section> </section> <section id="CD013790-sec-0032"> <h5 class="title">Secondary outcomes</h5> <p>All secondary outcomes are measures of <b>safety</b>. We only included studies that reported safety outcomes at one‐week follow‐up or longer.  </p> <p> <ul id="CD013790-list-0004"> <li> <p>Biomarkers of toxicant and carcinogen exposure. We included measures of exposure to tobacco‐specific N‐nitrosamines, polycyclic aromatic hydrocarbons, volatile organic compounds, and CO (see <a href="./appendices#CD013790-sec-0114">Appendix 1</a> for details on associations with health outcomes). </p> </li> <li> <p>Biomarkers of harm, also known as surrogate endpoints. We included measures of lung function (forced expiratory volume in one second (FEV<sub>1</sub>), forced vital capacity (FVC), and FEV<sub>1</sub>/FVC), blood pressure, heart rate, heart rate variability, and blood oxygen saturation. </p> </li> </ul> </p> </section> </section> </section> <section id="CD013790-sec-0033"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD013790-sec-0034"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases on 19 January 2021:</p> <p> <ul id="CD013790-list-0005"> <li> <p>Cochrane Tobacco Addiction Group's Specialised Register (for details of how this register is populated see the Cochrane Tobacco Addiction Group's website: <a href="https://tobacco.cochrane.org/resources/cochrane-tag-specialised-register" target="_blank">tobacco.cochrane.org/resources/cochrane-tag-specialised-register</a>); </p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2020, Issue 12);</p> </li> <li> <p>MEDLINE (OvidSP);</p> </li> <li> <p>Embase (OvidSP);</p> </li> <li> <p>PsycINFO (OvidSP);</p> </li> <li> <p>Business Source Complete;</p> </li> <li> <p>Factiva;</p> </li> <li> <p><a href="http://Clinicaltrials.gov" target="_blank">ClinicalTrials.gov</a>; </p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (ICTRP) (<a href="https://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>). </p> </li> </ul> </p> <p>We restricted the search to studies published since 2008, three years before the first internet searches for HTPs began (<a href="./references#CD013790-bbs2-0048" title='Google Trends.Worldwide internet searches for "heat-not-burn" from 2004–2020. trends.google.com/trends/explore?date=all&amp;q=heat-not-burn (accessed prior to 21 November 2021).'>Google Trends 2020</a>). </p> <p>The search terms were:</p> <p>heated tobacco OR carbon‐heated tobacco OR heat‐not‐burn OR heat not burn OR tobacco heating system$ OR tobacco heating device$ OR tobacco heating product$ OR tobacco vapor product$ OR tobacco vapour product$. We also searched for the term smoking AND (iqos OR glo OR ploom OR ifuse OR fuse OR pulze OR teeps OR pax OR mok OR lil OR iuoc OR htp OR thp OR ths OR chtp). </p> <p>As we were only interested in studies that used humans, we excluded those with the terms animal$ OR mice OR rat$ OR in vitro OR in silico OR in vivo in their title. </p> </section> <section id="CD013790-sec-0035"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of eligible studies found in the literature search.</p> <p>In order to identify government reports and in‐press or unpublished studies, we contacted relevant charities and authors of published research or trial protocols. We used the searches of <a href="http://Clinicaltrials.gov" target="_blank">ClinicalTrials.gov</a> and the ICTRP detailed above to identify trial registry records. </p> </section> </section> <section id="CD013790-sec-0036"> <h3 class="title" id="CD013790-sec-0036">Data collection and analysis</h3> <section id="CD013790-sec-0037"> <h4 class="title">Selection of studies</h4> <p>Two review authors (of HTB, JB, LK, ES, and LB) independently prescreened titles and abstracts of articles identified in the search, using a screening checklist. We resolved disagreements through discussion or referral to a third review author. We conducted screening using Covidence software (<a href="./references#CD013790-bbs2-0035" title="Veritas Health InnovationCovidence.Version accessed 10 May 2020. Melbourne, Australia: Veritas Health Innovation. Available at covidence.org.">Covidence</a>). </p> <p>Two review authors (of HTB, JB, LK, ES, and LB) independently screened the full text of articles that passed prescreening. We consulted a third review author to resolve any disagreements that were not resolved through discussion. </p> </section> <section id="CD013790-sec-0038"> <h4 class="title">Data extraction and management</h4> <p>We produced two custom data extraction forms: one for effectiveness and safety, and the other for smoking prevalence. Details of these forms are available in <a href="./appendices#CD013790-sec-0115">Appendix 2</a>. </p> <p>Two review authors (of HTB, JB, LK, ES, and LB) independently extracted data from included studies. When discrepancies could not be resolved through discussion, we referred to a third review author. We contacted authors of included studies if additional information was needed. </p> </section> <section id="CD013790-sec-0039"> <h4 class="title">Assessment of risk of bias in included studies</h4> <section id="CD013790-sec-0040"> <h5 class="title">Effectiveness and safety</h5> <p>Two review authors (of HTB, JB, LK, ES, and LB) independently assessed risks of bias for all included RCTs using the Cochrane risk of bias tool version 1. We followed the guidance as set out in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> to evaluate the following domains: sequence generation; allocation concealment; blinding of outcome assessment; incomplete outcome data; selective reporting; and other sources of bias (<a href="./references#CD013790-bbs2-0058" title="HigginsJP , AltmanDG , GøtzschePC , JüniP , MoherD , OxmanAD , et al.The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ2011;343:d5928. [DOI: 10.1136/bmj.d5928]">Higgins 2011</a>).  </p> </section> <section id="CD013790-sec-0041"> <h5 class="title">Smoking prevalence</h5> <p>Two review authors independently assessed risk of bias for included time‐series studies using the ROBINS‐I tool (<a href="./references#CD013790-bbs2-0083" title="SterneJ , HernánM , ReevesB , SavovićJ , BerkmanN , ViswanathanM , et al.ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ2016;355:4919. [DOI: 10.1136/bmj.i4919]">Sterne 2016</a>). </p> </section> </section> <section id="CD013790-sec-0042"> <h4 class="title">Measures of treatment effect</h4> <section id="CD013790-sec-0043"> <h5 class="title">Effectiveness and safety</h5> <p>We calculated risk ratios (RRs) and 95% confidence intervals (CIs) for dichotomous outcomes. </p> <p>For continuous safety data, we calculated mean differences on the raw (MD) or log‐transformed (LMD) scale and the corresponding 95% CIs between the heated tobacco and control groups at follow‐up. When studies reported geometric means, we converted these onto the (natural) log scale, and when studies being pooled reported mixtures of geometric and arithmetic means, we converted them all onto the log scale, using Method 1 described in <a href="./references#CD013790-bbs2-0057" title="HigginsJP , WhiteIR , Anzures-CabreraJ .Meta-analysis of skewed data: combining results reported on log-transformed or raw scales. Statistical Medicine2008;27(29):6072-92. [DOI: 10.1002/sim.3427]">Higgins 2008</a> where appropriate. </p> <p>We used the longest follow‐up data reported, with treatment effects calculated on an intention‐to‐treat basis where possible. </p> </section> <section id="CD013790-sec-0044"> <h5 class="title">Smoking prevalence</h5> <p>For interrupted time‐series studies, the treatment effect could have been reflected by the step change and change in trends in smoking prevalence or cigarette sales following the introduction of HTPs to the market (or the time point where they started gaining popularity), after adjusting for confounding variables. </p> <p>For multiple time‐series studies (in future review updates), the treatment effect of interest will be the association between HTP prevalence and smoking prevalence or cigarette sales, after adjusting for confounding variables. Where variables are log‐transformed, the resulting coefficient describes the percentage change in cigarette smoking prevalence associated with a 1% change in HTP prevalence. </p> </section> </section> <section id="CD013790-sec-0045"> <h4 class="title">Unit of analysis issues</h4> <section id="CD013790-sec-0046"> <h5 class="title">Effectiveness and safety</h5> <p>For RCTs with more than two intervention arms, we combined data from all relevant intervention conditions where HTPs were offered. For RCTs with more than two control arms, we combined data from each of these arms, and we chose the most appropriate comparator. If it is not appropriate to pool the intervention arms (in future updates) then we will split the control arm to act as a comparator to each separate intervention arm. If future updates of this review identify cluster‐RCTs, we will attempt to extract an estimate of the effect that accounts for the cluster design of the study. Where this is not reported, we will attempt to perform the correct analysis if required data are available. </p> </section> </section> <section id="CD013790-sec-0047"> <h4 class="title">Dealing with missing data</h4> <section id="CD013790-sec-0048"> <h5 class="title">Effectiveness</h5> <p>If we assess smoking cessation in future updates of this review, we will assume that people with missing data at follow‐up have not stopped smoking, as is common in the field. </p> </section> <section id="CD013790-sec-0049"> <h5 class="title">Safety</h5> <p>When assessing adverse and serious adverse events, we calculated the proportion of those available at follow‐up who experienced an event (when such data are available) rather than the proportion of people who were randomised, when follow‐up information was reported. When assessing biomarkers, we removed participants with missing follow‐up data from the analysis. </p> </section> <section id="CD013790-sec-0050"> <h5 class="title">Smoking prevalence</h5> <p>We did not expect issues with missing data in time‐series studies.</p> </section> </section> <section id="CD013790-sec-0051"> <h4 class="title">Assessment of heterogeneity</h4> <p>To assess whether to conduct meta‐analyses, we considered the characteristics of included studies to identify substantial clinical or methodological heterogeneity. If we deemed the studies to be sufficiently homogeneous to be combined meaningfully, we assessed statistical heterogeneity using the I<sup>2</sup> statistic. If the I<sup>2</sup> statistic was greater than 50%, we reported substantial heterogeneity. If I<sup>2</sup> was greater than 75%, we considered the appropriateness of presenting pooled results, and based this decision on consistency in the direction of effect across included studies. </p> </section> <section id="CD013790-sec-0052"> <h4 class="title">Assessment of reporting biases</h4> <p>In future updates of this review, we will assess reporting bias using funnel plots if we deem it appropriate to pool 10 or more studies in any analysis. The greater the asymmetry in the plots, the higher the risk of reporting bias. </p> </section> <section id="CD013790-sec-0053"> <h4 class="title">Data synthesis</h4> <section id="CD013790-sec-0054"> <h5 class="title">Effectiveness</h5> <p>The primary outcome of smoking cessation provides dichotomous data. Following the standard methods of the Cochrane Tobacco Addiction Group, we aimed to combine RRs and 95% CIs from individual studies using a Mantel‐Haenszel random‐effects model, to calculate pooled overall RRs with 95% CIs. </p> </section> <section id="CD013790-sec-0055"> <h5 class="title">Safety</h5> <p>For dichotomous safety outcomes (i.e. adverse and serious adverse events), we combined RRs and 95% CIs from individual studies using a Mantel‐Haenszel random‐effects model to calculate pooled overall RRs with 95% CIs. </p> <p>For continuous safety outcomes measuring biomarkers, we pooled the MDs or LMDs and measures of variance of individual studies using a generic inverse variance random‐effects model. </p> </section> <section id="CD013790-sec-0056"> <h5 class="title">Smoking prevalence</h5> <p>We aimed to calculate pooled estimates and their standard errors using a random‐effects model for each of three coefficients, when reported: step change in smoking prevalence or cigarette sales following the introduction of HTPs; change in these trends after the introduction; and changes associated with changes in prevalence or sale of HTPs. We did not pool time‐series studies with notably different time periods (e.g. weekly versus annual). </p> </section> </section> <section id="CD013790-sec-0057"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>For biomarker outcomes, we undertook subgroup analyses to investigate differences by whether analyses were per‐protocol or intention‐to‐treat. We define per‐protocol analyses as those that only included participants who exclusively (or almost exclusively) used the product they were assigned, whereas intention‐to‐treat analyses include all participants regardless of actual product use. </p> <p>If appropriate for future updates of this review, we will undertake subgroup analyses to investigate differences by: </p> <p> <ul id="CD013790-list-0006"> <li> <p>intensity of behavioural support provided;</p> </li> <li> <p>characteristics of HTP device (e.g. model used).</p> </li> </ul> </p> </section> <section id="CD013790-sec-0058"> <h4 class="title">Sensitivity analysis</h4> <p>We aimed to carry out sensitivity analyses removing studies:</p> <p> <ul id="CD013790-list-0007"> <li> <p>judged at high risk of bias for at least one domain;</p> </li> <li> <p>with a minimum length of follow‐up of less than four weeks (safety outcomes only);</p> </li> <li> <p>where participants were given carbon‐tip, rather than electronic, HTPs.</p> </li> </ul> </p> <p>If appropriate for future updates of this review, we will also carry out sensitivity analyses where we: </p> <p> <ul id="CD013790-list-0008"> <li> <p>remove studies that are funded by (or authors have received funding from) the tobacco industry; </p> </li> <li> <p>only classify participants as HTP users if they use their product daily (smoking prevalence only); </p> </li> <li> <p>only include interrupted time‐series studies in localities where HTPs achieved widespread use after they were introduced to market. </p> </li> </ul> </p> </section> <section id="CD013790-sec-0059"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We created summary of findings tables using GRADEpro GDT for all primary outcomes and for two biomarkers of exposure (NNAL and COHb), following the guidelines in <i>Cochrane Handbook of Systematic Reviews of Interventions</i> (<a href="./references#CD013790-bbs2-0049" title="McMaster University (developed by Evidence Prime)GRADEpro GDT.Version accessed 10 May 2020. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.">GRADEpro GDT</a>; <a href="./references#CD013790-bbs2-0059" title="Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Higgins 2021</a>; <a href="./references#CD013790-bbs2-0078" title="SchünemannHJ , HigginsJP , VistGE , GlasziouP , AklEA , SkoetzN , et al.Chapter 14: Completing 'Summary of findings' tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). The Cochrane Collaboration, 2020. Available from training.cochrane.org/handbook/archive/v6.1.">Schünemann 2020</a>). We chose NNAL and COHb because they are well‐established indicators of tobacco smoke exposure (<a href="./references#CD013790-bbs2-0034" title="ChangCM , EdwardsSH , ArabA , Del Valle-PineroAY , YangL , HatsukamiDK .Biomarkers of tobacco exposure: summary of an FDA-sponsored public workshop. Cancer Epidemiology, Biomarkers &amp; Prevention2017;26(3):291-302. [DOI: 10.1158/1055-9965.EPI-16-0675]">Chang 2017</a>; <a href="./references#CD013790-bbs2-0055" title="HedbladB , ÖgrenM , EngströmG , WollmerP , JanzonL .Heterogeneity of cardiovascular risk among smokers is related to degree of carbon monoxide exposure. Atherosclerosis2005;179(1):347-64. [DOI: 10.1016/j.atherosclerosis.2004.10.005]">Hedblad 2005</a>). We used the five GRADE considerations (risk of bias, inconsistency, imprecision, indirectness, and publication bias) to assess the certainty of the body of evidence for each of these outcomes.  </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD013790-sec-0060" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD013790-sec-0060"></div> <section id="CD013790-sec-0061"> <h3 class="title">Description of studies</h3> <section id="CD013790-sec-0062"> <h4 class="title">Results of the search</h4> <p>Our bibliographic database searches identified 1504 non‐duplicate records (<a href="#CD013790-fig-0001">Figure 1</a>). We found a further four records through screening references in the papers identified through electronic searches. We screened all records and retrieved the full‐text of 121 potentially relevant articles. After screening and checking the full texts, we included 23 records, representing 13 completed (<a href="./references#CD013790-sec-0127" title="">Characteristics of included studies</a>) and three ongoing studies (<a href="./references#CD013790-sec-0129" title="">Characteristics of ongoing studies</a>). We excluded 98 records during full text screening, and we give reasons for exclusion for 11 studies (<a href="./references#CD013790-sec-0128" title="">Characteristics of excluded studies</a>). </p> <div class="figure" id="CD013790-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="original image" data-id="CD013790-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"></div> </div> </section> <section id="CD013790-sec-0063"> <h4 class="title">Included studies</h4> <p>A summary of the 13 included studies is given below. Further details of each study can be found in the <a href="./references#CD013790-sec-0127" title="">Characteristics of included studies</a> section. </p> <section id="CD013790-sec-0064"> <h5 class="title">Participants</h5> <p>Of the 13 included studies, 11 collected data from participants. Two studies used sales data and are thus excluded from subsequent discussion of participant characteristics. A total of 2666 participants were recruited across the 11 RCTs. Three studies were conducted in Japan, three in the USA, two in Poland, two in the UK, and one in South Korea. These studies were conducted in adults who smoked cigarettes. Seven studies exclusively recruited participants who were not motivated to quit smoking cigarettes. One study only recruited participants diagnosed with generalised chronic periodontitis (<a href="./references#CD013790-bbs2-0008" title="NCT03364751.Effect of switching from cigarette smoking to the use of IQOS on periodontitis treatment outcome. clinicaltrials.gov/ct2/show/NCT03364751 (first received 7 December 2017). ">NCT03364751</a>). Three studies only recruited people who were Japanese or of "Japanese ethnicity" (<a href="./references#CD013790-bbs2-0005" title="LüdickeF , PicavetP , BakerG , HazizaC , PouxV , LamaN , et al.Effects of switching to the menthol tobacco heating system 2.2, smoking abstinence, or continued cigarette smoking on clinically relevant risk markers: a randomized, controlled, open-Label, multicenter study in sequential confinement and ambulatory settings (Part 2). Nicotine &amp; Tobacco Research2018;20(2):173-82. [DOI: 10.1093/ntr/ntx028]LüdickeF , PicavetP , BakerG , HazizaC , PouxV , LamaN , et al.Effects of switching to the Tobacco Heating System 2.2 menthol, smoking abstinence, or continued cigarette smoking on biomarkers of exposure: a randomized, controlled, open-label, multicenter study in sequential confinement and ambulatory settings (Part 1). Nicotine &amp; Tobacco Research2018;20(2):161-72. [DOI: 10.1093/ntr/ntw287]NCT01970995.Reduced exposure study using THS 2.2 menthol with 5 days in a confinement setting and 85 days in an ambulatory setting. clinicaltrials.gov/ct2/show/NCT01970995 (first received 28 October 2013). Philip Morris Products SA.Module 7.3.1 of the modified risk tobacco product (MRTP) application from Philip Morris Products S.A. Submission to the U.S. Food &amp; Drug Administration. Study code: 07 REXA07JP2017. ">Lüdicke 2018</a>; <a href="./references#CD013790-bbs2-0008" title="NCT03364751.Effect of switching from cigarette smoking to the use of IQOS on periodontitis treatment outcome. clinicaltrials.gov/ct2/show/NCT03364751 (first received 7 December 2017). ">NCT03364751</a>; <a href="./references#CD013790-bbs2-0012" title="TrickerAR , KanadaS , TakadaK , Martin LeroyC , LindnerD , SchorpMK , et al.Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 5: 8-day randomized clinical trial in Japan. Regulatory Toxicology and Pharmacology2012;64(Suppl):S54-S63. [DOI: 10.1016/j.yrtph.2012.08.003]">Tricker 2012b</a>), while <a href="./references#CD013790-bbs2-0007" title="Martin LeroyC , Jarus-DziedzicK , AncerewiczJ , LindnerD , KuleszaA , MagnetteJ .Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 7: a one-month, randomized, ambulatory, controlled clinical study in Poland. Regulatory Toxicology and Pharmacology2012;64(Suppl):S74-S84. [DOI: 10.1016/j.yrtph.2012.08.006]">Martin 2012</a> only recruited those of "Caucasian ethnicity". Participants stayed in confinement in a clinic for the duration of the trial in three studies (<a href="./references#CD013790-bbs2-0011" title="TrickerAR , JangI , Martin LeroyC , LindnerD , DempseyR .Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 4: eight-day randomized clinical trial in Korea. Regulatory Toxicology and Pharmacology2012;64(Suppl):S45-S53. [DOI: 10.1016/j.yrtph.2012.08.013]">Tricker 2012a</a>; <a href="./references#CD013790-bbs2-0012" title="TrickerAR , KanadaS , TakadaK , Martin LeroyC , LindnerD , SchorpMK , et al.Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 5: 8-day randomized clinical trial in Japan. Regulatory Toxicology and Pharmacology2012;64(Suppl):S54-S63. [DOI: 10.1016/j.yrtph.2012.08.003]">Tricker 2012b</a>; <a href="./references#CD013790-bbs2-0013" title="TrickerAR , StewartAJ , Martin LeroyC , LindnerD , SchorpMK , DempseyR .Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 3: eight-day randomized clinical trial in the UK. Regulatory Toxicology and Pharmacology2012;64(Suppl):S35-S44. [DOI: 10.1016/j.yrtph.2012.08.010]">Tricker 2012c</a>). Another three studies started with a confinement period of five days, before moving to an ambulatory setting for the rest of the trial (<a href="./references#CD013790-bbs2-0001" title="BosilkovskaM , TranCT , deLa BourdonnayeG , TaranuB , BenzimraM , HazizaC .Exposure to harmful and potentially harmful constituents decreased in smokers switching to carbon-heated tobacco product. Toxicology Letters2020;330:30-40. [DOI: 10.1016/j.toxlet.2020.04.013]NCT02641587.Reduced exposure study using the CHTP 1.2 with 5 days in a confinement setting followed by 85 days in an ambulatory setting. clinicaltrials.gov/ct2/show/NCT02641587 (first received 29 December 2015). ">Bosilkovska 2020</a>; <a href="./references#CD013790-bbs2-0004" title="HazizaC , deLa BourdonnayeG , DonelliA , PouxV , SkiadaD , WeitkunatR , et al.Favorable changes in biomarkers of potential harm to reduce the adverse health effects of smoking in smokers switching to the menthol Tobacco Heating System 2.2 for 3 months (Part 2). Nicotine &amp; Tobacco Research2019;22(4):549-59. [DOI: 10.1093/ntr/ntz084]HazizaC , deLa BourdonnayeG , DonelliA , PouxV , SkiadaD , WeitkunatR , et al.Reduction in exposure to selected harmful and potentially harmful constituents approaching those observed upon smoking abstinence in smokers switching to the menthol tobacco heating system 2.2 for 3 months (Part 1). Nicotine &amp; Tobacco Research2019;22(4):539-48. [DOI: 10.1093/ntr/ntz013]NCT01989156.Reduced exposure study using THS 2.2 menthol with 5 days in a confinement setting followed by 86 days in an ambulatory setting. clinicaltrials.gov/ct2/show/NCT01989156 (first received 20 November 2013). Philip Morris Products SA.Module 7.3.1 of the modified risk tobacco product (MRTP) application from Philip Morris Products S.A. Submission to the U.S. Food &amp; Drug Administration. Study code: 08 REXA08US2017. ">Haziza 2019</a>; <a href="./references#CD013790-bbs2-0005" title="LüdickeF , PicavetP , BakerG , HazizaC , PouxV , LamaN , et al.Effects of switching to the menthol tobacco heating system 2.2, smoking abstinence, or continued cigarette smoking on clinically relevant risk markers: a randomized, controlled, open-Label, multicenter study in sequential confinement and ambulatory settings (Part 2). Nicotine &amp; Tobacco Research2018;20(2):173-82. [DOI: 10.1093/ntr/ntx028]LüdickeF , PicavetP , BakerG , HazizaC , PouxV , LamaN , et al.Effects of switching to the Tobacco Heating System 2.2 menthol, smoking abstinence, or continued cigarette smoking on biomarkers of exposure: a randomized, controlled, open-label, multicenter study in sequential confinement and ambulatory settings (Part 1). Nicotine &amp; Tobacco Research2018;20(2):161-72. [DOI: 10.1093/ntr/ntw287]NCT01970995.Reduced exposure study using THS 2.2 menthol with 5 days in a confinement setting and 85 days in an ambulatory setting. clinicaltrials.gov/ct2/show/NCT01970995 (first received 28 October 2013). Philip Morris Products SA.Module 7.3.1 of the modified risk tobacco product (MRTP) application from Philip Morris Products S.A. Submission to the U.S. Food &amp; Drug Administration. Study code: 07 REXA07JP2017. ">Lüdicke 2018</a>). The remaining five studies used an ambulatory setting with regular clinical visits. Median follow‐up length was 13 weeks, and three studies had less than four weeks of follow‐up (<a href="./references#CD013790-bbs2-0011" title="TrickerAR , JangI , Martin LeroyC , LindnerD , DempseyR .Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 4: eight-day randomized clinical trial in Korea. Regulatory Toxicology and Pharmacology2012;64(Suppl):S45-S53. [DOI: 10.1016/j.yrtph.2012.08.013]">Tricker 2012a</a>; <a href="./references#CD013790-bbs2-0012" title="TrickerAR , KanadaS , TakadaK , Martin LeroyC , LindnerD , SchorpMK , et al.Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 5: 8-day randomized clinical trial in Japan. Regulatory Toxicology and Pharmacology2012;64(Suppl):S54-S63. [DOI: 10.1016/j.yrtph.2012.08.003]">Tricker 2012b</a>; <a href="./references#CD013790-bbs2-0013" title="TrickerAR , StewartAJ , Martin LeroyC , LindnerD , SchorpMK , DempseyR .Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 3: eight-day randomized clinical trial in the UK. Regulatory Toxicology and Pharmacology2012;64(Suppl):S35-S44. [DOI: 10.1016/j.yrtph.2012.08.010]">Tricker 2012c</a>). </p> </section> <section id="CD013790-sec-0065"> <h5 class="title">Interventions and comparators</h5> <p>All 11 included RCTs gave HTPs to participants. Two studies provided participants with the carbon‐tip products 'CHTP 1.2' and 'Eclipse' (<a href="./references#CD013790-bbs2-0001" title="BosilkovskaM , TranCT , deLa BourdonnayeG , TaranuB , BenzimraM , HazizaC .Exposure to harmful and potentially harmful constituents decreased in smokers switching to carbon-heated tobacco product. Toxicology Letters2020;330:30-40. [DOI: 10.1016/j.toxlet.2020.04.013]NCT02641587.Reduced exposure study using the CHTP 1.2 with 5 days in a confinement setting followed by 85 days in an ambulatory setting. clinicaltrials.gov/ct2/show/NCT02641587 (first received 29 December 2015). ">Bosilkovska 2020</a>; <a href="./references#CD013790-bbs2-0009" title="NCT02061917.Switching from usual brand cigarettes to a tobacco-heating cigarette or snus (QoL). clinicaltrials.gov/ct2/show/NCT02061917 (first received 13 February 2014). OgdenM , MaranoKM , JonesBA , MorganWT , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 2. Biomarkers of exposure. Biomarkers2015;20(6-7):391-403. [DOI: 10.3109/1354750X.2015.1094134]OgdenM , MaranoKM , JonesBA , MorganWT , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 3. Biomarkers of biological effect. Biomarkers2015;20(6-7):404-10. [DOI: 10.3109/1354750X.2015.1094135]OgdenM , MaranoKM , JonesBA , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 1. Study design and methodology. Biomarkers2015;20(6-7):382-90. [DOI: 10.3109/1354750X.2015.1094133]">Ogden 2015</a>). All others provided electronic heating devices alongside tobacco sticks, with PMI's IQOS‐family products (or their predecessors) provided in eight studies and BAT's glo‐family products in one study (<a href="./references#CD013790-bbs2-0003" title="GaleN , McEwanM , CamachoOM , HardieG , MurphyJ , ProctorCJ .Changes in biomarkers of exposure on switching from a conventional cigarette to the glo tobacco heating product: a randomized, controlled ambulatory study. Nicotine &amp; Tobacco Research2020;23(3):584-91. [DOI: 10.1093/ntr/ntaa135]GaleN , McEwanM , CamachoOM , HardieG , ProctorCJ , MurphyJ .Changes in biomarkers after 180 days of tobacco heating product use: a randomised trial. Internal and Emergency Medicine2021;16:2201-12. [DOI: 10.1007/s11739-021-02798-6]ISRCTN81075760.A study to examine health effect indicators when a smoker switches to using a tobacco heating product. www.isrctn.com/ISRCTN81075760 (first received 9 January 2018). [DOI: 10.1186/ISRCTN81075760]">Gale 2020</a>). </p> <p>All 11 RCTs compared participants randomised to receive a HTP or to continue smoking cigarettes. Five studies also had tobacco abstinence as an additional comparator and one study had snus use as an additional comparator (<a href="./references#CD013790-bbs2-0009" title="NCT02061917.Switching from usual brand cigarettes to a tobacco-heating cigarette or snus (QoL). clinicaltrials.gov/ct2/show/NCT02061917 (first received 13 February 2014). OgdenM , MaranoKM , JonesBA , MorganWT , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 2. Biomarkers of exposure. Biomarkers2015;20(6-7):391-403. [DOI: 10.3109/1354750X.2015.1094134]OgdenM , MaranoKM , JonesBA , MorganWT , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 3. Biomarkers of biological effect. Biomarkers2015;20(6-7):404-10. [DOI: 10.3109/1354750X.2015.1094135]OgdenM , MaranoKM , JonesBA , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 1. Study design and methodology. Biomarkers2015;20(6-7):382-90. [DOI: 10.3109/1354750X.2015.1094133]">Ogden 2015</a>). Summaries of study results by comparator are available in <a href="#CD013790-sec-0075">Effects of interventions</a>. Further details on the intervention and comparator groups for each are available in the <a href="./references#CD013790-sec-0127" title="">Characteristics of included studies</a> section. </p> <p>There were two interrupted time‐series studies using cigarette sales data from Japan. The intervention in these studies was the introduction of heated tobacco to market, with the launch of IQOS in 2015 or 2016 (depending on region).  </p> </section> <section id="CD013790-sec-0066"> <h5 class="title">Outcomes</h5> <p>Of the 13 included studies:</p> <p> <ul id="CD013790-list-0009"> <li> <p>none reported smoking cessation rates;</p> </li> <li> <p>10 reported data on adverse events (four of which did not provide data in each trial arm). Commonly reported adverse events included cough, headache, gastrointestinal issues (e.g. diarrhoea), dry mouth, hyperglycaemia, and decreased haemoglobin; </p> </li> <li> <p>10 reported data on serious adverse events. Most studies defined serious adverse events as medical incidents that were potentially life‐threatening, require hospitalisation, resulted in disability or death, of a combination of these; </p> </li> <li> <p>11 reported data on at least one biomarker of toxicant and carcinogen exposure;</p> </li> <li> <p>five reported data on at least one biomarker of harm;</p> </li> <li> <p>none reported time‐series data on smoking prevalence;</p> </li> <li> <p>two reported time‐series data on cigarette sales.</p> </li> </ul> </p> </section> <section id="CD013790-sec-0067"> <h5 class="title">Study types and funding</h5> <p>Eleven studies were RCTs and two were observational time‐series studies. All 11 RCTs were funded by the tobacco industry. One time‐series study was funded through government grants, while the other had no specific funding. </p> </section> </section> <section id="CD013790-sec-0068"> <h4 class="title">Excluded studies</h4> <p><a href="#CD013790-fig-0001">Figure 1</a> shows the most common reasons for exclusion of studies during full‐text screening, which were: duplicate reports; less than one week of follow‐up; and wrong study design (e.g. testing acute rather than extended effects of HTP use). </p> <p>In the <a href="./references#CD013790-sec-0128" title="">Characteristics of excluded studies</a> table, we list more detailed exclusion reasons for 11 of these studies. This list is not comprehensive, only containing studies that a reader might plausibly expect be included.  </p> </section> </section> <section id="CD013790-sec-0069"> <h3 class="title">Risk of bias in included studies</h3> <p>Overall, we judged eight of the 11 included RCTs at unclear risk of bias and three at high risk of bias, assessed using the ROB v1 criteria (<a href="./references#CD013790-bbs2-0058" title="HigginsJP , AltmanDG , GøtzschePC , JüniP , MoherD , OxmanAD , et al.The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ2011;343:d5928. [DOI: 10.1136/bmj.d5928]">Higgins 2011</a>). <a href="#CD013790-fig-0002">Figure 2</a> shows judgements across the risk of bias domains for each RCT. Detailed rationale for these judgements can be found in the <a href="./references#CD013790-sec-0127" title="">Characteristics of included studies</a>. </p> <div class="figure" id="CD013790-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="review authors' judgements about risk of bias domains for each included RCT study. Risk of bias for time‐series studies (Cummings 2020; Stoklosa 2020), assessed using ROBINS‐I tool, are shown in Appendix 3 and Appendix 4. " data-id="CD013790-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>review authors' judgements about risk of bias domains for each included RCT study. Risk of bias for time‐series studies (<a href="./references#CD013790-bbs2-0002" title="CummingsKM , NahhasGJ , SweanorDT .What is accounting for the rapid decline in cigarette sales in Japan?International Journal of Environmental Research and Public Health2020;17(10):3570. [DOI: 10.3390/ijerph17103570]">Cummings 2020</a>; <a href="./references#CD013790-bbs2-0010" title="StoklosaM , CahnZ , LiberA , NargisN , DropeJ .Effect of IQOS introduction on cigarette sales: evidence of decline and replacement. Tobacco Control2020;29(4):381-7. [DOI: 10.1136/tobaccocontrol-2019-054998]">Stoklosa 2020</a>), assessed using ROBINS‐I tool, are shown in <a href="./appendices#CD013790-sec-0116">Appendix 3</a> and <a href="./appendices#CD013790-sec-0117">Appendix 4</a>.  </p> </div> </div> </div> <p>Risk of bias for the two included time‐series studies was assessed using the ROBINS‐I tool (<a href="./references#CD013790-bbs2-0083" title="SterneJ , HernánM , ReevesB , SavovićJ , BerkmanN , ViswanathanM , et al.ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ2016;355:4919. [DOI: 10.1136/bmj.i4919]">Sterne 2016</a>). One time‐series study was at moderate risk of bias, while the other was at serious risk. Detailed risk of bias assessments for these time‐series studies can be found in the appendices (<a href="./appendices#CD013790-sec-0116">Appendix 3</a>; <a href="./appendices#CD013790-sec-0117">Appendix 4</a>). </p> <section id="CD013790-sec-0070"> <h4 class="title">Allocation</h4> <p>All included RCTs were at unclear risk of selection bias, as there was no or insufficient information about random sequence generation or allocation concealment, or both.  </p> </section> <section id="CD013790-sec-0071"> <h4 class="title">Blinding</h4> <p>We judged all studies at low risk of detection bias, as most reported outcomes were biochemical and hence judged at low risk of differential misreport. We planned to assess performance bias for smoking cessation outcomes, with studies judged at low risk if intervention and control arms received similar levels of behavioural support. As no study reported on smoking cessation outcomes, performance bias was not assessed. </p> </section> <section id="CD013790-sec-0072"> <h4 class="title">Incomplete outcome data</h4> <p>Seven studies were at low risk of attrition bias, due to high and similar rates of follow‐up across treatment and comparator arms (<a href="./references#CD013790-bbs2-0001" title="BosilkovskaM , TranCT , deLa BourdonnayeG , TaranuB , BenzimraM , HazizaC .Exposure to harmful and potentially harmful constituents decreased in smokers switching to carbon-heated tobacco product. Toxicology Letters2020;330:30-40. [DOI: 10.1016/j.toxlet.2020.04.013]NCT02641587.Reduced exposure study using the CHTP 1.2 with 5 days in a confinement setting followed by 85 days in an ambulatory setting. clinicaltrials.gov/ct2/show/NCT02641587 (first received 29 December 2015). ">Bosilkovska 2020</a>; <a href="./references#CD013790-bbs2-0003" title="GaleN , McEwanM , CamachoOM , HardieG , MurphyJ , ProctorCJ .Changes in biomarkers of exposure on switching from a conventional cigarette to the glo tobacco heating product: a randomized, controlled ambulatory study. Nicotine &amp; Tobacco Research2020;23(3):584-91. [DOI: 10.1093/ntr/ntaa135]GaleN , McEwanM , CamachoOM , HardieG , ProctorCJ , MurphyJ .Changes in biomarkers after 180 days of tobacco heating product use: a randomised trial. Internal and Emergency Medicine2021;16:2201-12. [DOI: 10.1007/s11739-021-02798-6]ISRCTN81075760.A study to examine health effect indicators when a smoker switches to using a tobacco heating product. www.isrctn.com/ISRCTN81075760 (first received 9 January 2018). [DOI: 10.1186/ISRCTN81075760]">Gale 2020</a>; <a href="./references#CD013790-bbs2-0005" title="LüdickeF , PicavetP , BakerG , HazizaC , PouxV , LamaN , et al.Effects of switching to the menthol tobacco heating system 2.2, smoking abstinence, or continued cigarette smoking on clinically relevant risk markers: a randomized, controlled, open-Label, multicenter study in sequential confinement and ambulatory settings (Part 2). Nicotine &amp; Tobacco Research2018;20(2):173-82. [DOI: 10.1093/ntr/ntx028]LüdickeF , PicavetP , BakerG , HazizaC , PouxV , LamaN , et al.Effects of switching to the Tobacco Heating System 2.2 menthol, smoking abstinence, or continued cigarette smoking on biomarkers of exposure: a randomized, controlled, open-label, multicenter study in sequential confinement and ambulatory settings (Part 1). Nicotine &amp; Tobacco Research2018;20(2):161-72. [DOI: 10.1093/ntr/ntw287]NCT01970995.Reduced exposure study using THS 2.2 menthol with 5 days in a confinement setting and 85 days in an ambulatory setting. clinicaltrials.gov/ct2/show/NCT01970995 (first received 28 October 2013). Philip Morris Products SA.Module 7.3.1 of the modified risk tobacco product (MRTP) application from Philip Morris Products S.A. Submission to the U.S. Food &amp; Drug Administration. Study code: 07 REXA07JP2017. ">Lüdicke 2018</a>; <a href="./references#CD013790-bbs2-0006" title="AnsariSM , LamaN , BlancN , BosilkovskaM , DonelliA , PicavetP , et al.Evaluation of biological and functional changes in healthy smokers switching to the Tobacco Heating System 2.2 versus continued tobacco smoking: protocol for a randomized, controlled, multicenter study. JMIR Research Protocols2018;7(8):e11294. [DOI: 10.2196/11294]LüdickeF , AnsariSM , LamaN , BlancN , BosilkovskaM , DonelliA , et al.Effects of switching to a heat-not-burn tobacco product on biologically relevant biomarkers to assess a candidate modified risk tobacco product: a randomized trial. Cancer Epidemiology, Biomarkers &amp; Prevention2019;28(11):1934-43. [DOI: 10.1158/1055-9965.EPI-18-0915]NCT02396381.Evaluation of biological and functional changes in healthy smokers after switching to THS 2.2 for 26 weeks. clinicaltrials.gov/ct2/show/NCT02396381 (first received 24 March 2015). NCT02649556.A 26-week extension of the ZRHR-ERS-09-US study evaluating biological and functional changes in healthy smokers after switching to THS 2.2. clinicaltrials.gov/ct2/show/NCT02649556 (first received 7 January 2016). ">Lüdicke 2019</a>; <a href="./references#CD013790-bbs2-0007" title="Martin LeroyC , Jarus-DziedzicK , AncerewiczJ , LindnerD , KuleszaA , MagnetteJ .Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 7: a one-month, randomized, ambulatory, controlled clinical study in Poland. Regulatory Toxicology and Pharmacology2012;64(Suppl):S74-S84. [DOI: 10.1016/j.yrtph.2012.08.006]">Martin 2012</a>; <a href="./references#CD013790-bbs2-0008" title="NCT03364751.Effect of switching from cigarette smoking to the use of IQOS on periodontitis treatment outcome. clinicaltrials.gov/ct2/show/NCT03364751 (first received 7 December 2017). ">NCT03364751</a>; <a href="./references#CD013790-bbs2-0009" title="NCT02061917.Switching from usual brand cigarettes to a tobacco-heating cigarette or snus (QoL). clinicaltrials.gov/ct2/show/NCT02061917 (first received 13 February 2014). OgdenM , MaranoKM , JonesBA , MorganWT , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 2. Biomarkers of exposure. Biomarkers2015;20(6-7):391-403. [DOI: 10.3109/1354750X.2015.1094134]OgdenM , MaranoKM , JonesBA , MorganWT , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 3. Biomarkers of biological effect. Biomarkers2015;20(6-7):404-10. [DOI: 10.3109/1354750X.2015.1094135]OgdenM , MaranoKM , JonesBA , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 1. Study design and methodology. Biomarkers2015;20(6-7):382-90. [DOI: 10.3109/1354750X.2015.1094133]">Ogden 2015</a>). Three studies were at unclear risk as they did not provide sufficient details about attrition (<a href="./references#CD013790-bbs2-0011" title="TrickerAR , JangI , Martin LeroyC , LindnerD , DempseyR .Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 4: eight-day randomized clinical trial in Korea. Regulatory Toxicology and Pharmacology2012;64(Suppl):S45-S53. [DOI: 10.1016/j.yrtph.2012.08.013]">Tricker 2012a</a>; <a href="./references#CD013790-bbs2-0012" title="TrickerAR , KanadaS , TakadaK , Martin LeroyC , LindnerD , SchorpMK , et al.Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 5: 8-day randomized clinical trial in Japan. Regulatory Toxicology and Pharmacology2012;64(Suppl):S54-S63. [DOI: 10.1016/j.yrtph.2012.08.003]">Tricker 2012b</a>; <a href="./references#CD013790-bbs2-0013" title="TrickerAR , StewartAJ , Martin LeroyC , LindnerD , SchorpMK , DempseyR .Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 3: eight-day randomized clinical trial in the UK. Regulatory Toxicology and Pharmacology2012;64(Suppl):S35-S44. [DOI: 10.1016/j.yrtph.2012.08.010]">Tricker 2012c</a>). <a href="./references#CD013790-bbs2-0004" title="HazizaC , deLa BourdonnayeG , DonelliA , PouxV , SkiadaD , WeitkunatR , et al.Favorable changes in biomarkers of potential harm to reduce the adverse health effects of smoking in smokers switching to the menthol Tobacco Heating System 2.2 for 3 months (Part 2). Nicotine &amp; Tobacco Research2019;22(4):549-59. [DOI: 10.1093/ntr/ntz084]HazizaC , deLa BourdonnayeG , DonelliA , PouxV , SkiadaD , WeitkunatR , et al.Reduction in exposure to selected harmful and potentially harmful constituents approaching those observed upon smoking abstinence in smokers switching to the menthol tobacco heating system 2.2 for 3 months (Part 1). Nicotine &amp; Tobacco Research2019;22(4):539-48. [DOI: 10.1093/ntr/ntz013]NCT01989156.Reduced exposure study using THS 2.2 menthol with 5 days in a confinement setting followed by 86 days in an ambulatory setting. clinicaltrials.gov/ct2/show/NCT01989156 (first received 20 November 2013). Philip Morris Products SA.Module 7.3.1 of the modified risk tobacco product (MRTP) application from Philip Morris Products S.A. Submission to the U.S. Food &amp; Drug Administration. Study code: 08 REXA08US2017. ">Haziza 2019</a> was at high risk of attrition bias due to substantial loss to follow‐up that was greater in the heated tobacco arm. </p> </section> <section id="CD013790-sec-0073"> <h4 class="title">Selective reporting</h4> <p>We judged five studies at low risk of reporting bias, as all prespecified outcomes were reported (<a href="./references#CD013790-bbs2-0001" title="BosilkovskaM , TranCT , deLa BourdonnayeG , TaranuB , BenzimraM , HazizaC .Exposure to harmful and potentially harmful constituents decreased in smokers switching to carbon-heated tobacco product. Toxicology Letters2020;330:30-40. [DOI: 10.1016/j.toxlet.2020.04.013]NCT02641587.Reduced exposure study using the CHTP 1.2 with 5 days in a confinement setting followed by 85 days in an ambulatory setting. clinicaltrials.gov/ct2/show/NCT02641587 (first received 29 December 2015). ">Bosilkovska 2020</a>; <a href="./references#CD013790-bbs2-0003" title="GaleN , McEwanM , CamachoOM , HardieG , MurphyJ , ProctorCJ .Changes in biomarkers of exposure on switching from a conventional cigarette to the glo tobacco heating product: a randomized, controlled ambulatory study. Nicotine &amp; Tobacco Research2020;23(3):584-91. [DOI: 10.1093/ntr/ntaa135]GaleN , McEwanM , CamachoOM , HardieG , ProctorCJ , MurphyJ .Changes in biomarkers after 180 days of tobacco heating product use: a randomised trial. Internal and Emergency Medicine2021;16:2201-12. [DOI: 10.1007/s11739-021-02798-6]ISRCTN81075760.A study to examine health effect indicators when a smoker switches to using a tobacco heating product. www.isrctn.com/ISRCTN81075760 (first received 9 January 2018). [DOI: 10.1186/ISRCTN81075760]">Gale 2020</a>; <a href="./references#CD013790-bbs2-0004" title="HazizaC , deLa BourdonnayeG , DonelliA , PouxV , SkiadaD , WeitkunatR , et al.Favorable changes in biomarkers of potential harm to reduce the adverse health effects of smoking in smokers switching to the menthol Tobacco Heating System 2.2 for 3 months (Part 2). Nicotine &amp; Tobacco Research2019;22(4):549-59. [DOI: 10.1093/ntr/ntz084]HazizaC , deLa BourdonnayeG , DonelliA , PouxV , SkiadaD , WeitkunatR , et al.Reduction in exposure to selected harmful and potentially harmful constituents approaching those observed upon smoking abstinence in smokers switching to the menthol tobacco heating system 2.2 for 3 months (Part 1). Nicotine &amp; Tobacco Research2019;22(4):539-48. [DOI: 10.1093/ntr/ntz013]NCT01989156.Reduced exposure study using THS 2.2 menthol with 5 days in a confinement setting followed by 86 days in an ambulatory setting. clinicaltrials.gov/ct2/show/NCT01989156 (first received 20 November 2013). Philip Morris Products SA.Module 7.3.1 of the modified risk tobacco product (MRTP) application from Philip Morris Products S.A. Submission to the U.S. Food &amp; Drug Administration. Study code: 08 REXA08US2017. ">Haziza 2019</a>; <a href="./references#CD013790-bbs2-0006" title="AnsariSM , LamaN , BlancN , BosilkovskaM , DonelliA , PicavetP , et al.Evaluation of biological and functional changes in healthy smokers switching to the Tobacco Heating System 2.2 versus continued tobacco smoking: protocol for a randomized, controlled, multicenter study. JMIR Research Protocols2018;7(8):e11294. [DOI: 10.2196/11294]LüdickeF , AnsariSM , LamaN , BlancN , BosilkovskaM , DonelliA , et al.Effects of switching to a heat-not-burn tobacco product on biologically relevant biomarkers to assess a candidate modified risk tobacco product: a randomized trial. Cancer Epidemiology, Biomarkers &amp; Prevention2019;28(11):1934-43. [DOI: 10.1158/1055-9965.EPI-18-0915]NCT02396381.Evaluation of biological and functional changes in healthy smokers after switching to THS 2.2 for 26 weeks. clinicaltrials.gov/ct2/show/NCT02396381 (first received 24 March 2015). NCT02649556.A 26-week extension of the ZRHR-ERS-09-US study evaluating biological and functional changes in healthy smokers after switching to THS 2.2. clinicaltrials.gov/ct2/show/NCT02649556 (first received 7 January 2016). ">Lüdicke 2019</a>; <a href="./references#CD013790-bbs2-0008" title="NCT03364751.Effect of switching from cigarette smoking to the use of IQOS on periodontitis treatment outcome. clinicaltrials.gov/ct2/show/NCT03364751 (first received 7 December 2017). ">NCT03364751</a>). Five studies were at unclear risk as there was no preregistered study protocol (<a href="./references#CD013790-bbs2-0007" title="Martin LeroyC , Jarus-DziedzicK , AncerewiczJ , LindnerD , KuleszaA , MagnetteJ .Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 7: a one-month, randomized, ambulatory, controlled clinical study in Poland. Regulatory Toxicology and Pharmacology2012;64(Suppl):S74-S84. [DOI: 10.1016/j.yrtph.2012.08.006]">Martin 2012</a>; <a href="./references#CD013790-bbs2-0009" title="NCT02061917.Switching from usual brand cigarettes to a tobacco-heating cigarette or snus (QoL). clinicaltrials.gov/ct2/show/NCT02061917 (first received 13 February 2014). OgdenM , MaranoKM , JonesBA , MorganWT , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 2. Biomarkers of exposure. Biomarkers2015;20(6-7):391-403. [DOI: 10.3109/1354750X.2015.1094134]OgdenM , MaranoKM , JonesBA , MorganWT , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 3. Biomarkers of biological effect. Biomarkers2015;20(6-7):404-10. [DOI: 10.3109/1354750X.2015.1094135]OgdenM , MaranoKM , JonesBA , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 1. Study design and methodology. Biomarkers2015;20(6-7):382-90. [DOI: 10.3109/1354750X.2015.1094133]">Ogden 2015</a>; <a href="./references#CD013790-bbs2-0011" title="TrickerAR , JangI , Martin LeroyC , LindnerD , DempseyR .Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 4: eight-day randomized clinical trial in Korea. Regulatory Toxicology and Pharmacology2012;64(Suppl):S45-S53. [DOI: 10.1016/j.yrtph.2012.08.013]">Tricker 2012a</a>; <a href="./references#CD013790-bbs2-0012" title="TrickerAR , KanadaS , TakadaK , Martin LeroyC , LindnerD , SchorpMK , et al.Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 5: 8-day randomized clinical trial in Japan. Regulatory Toxicology and Pharmacology2012;64(Suppl):S54-S63. [DOI: 10.1016/j.yrtph.2012.08.003]">Tricker 2012b</a>; <a href="./references#CD013790-bbs2-0013" title="TrickerAR , StewartAJ , Martin LeroyC , LindnerD , SchorpMK , DempseyR .Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 3: eight-day randomized clinical trial in the UK. Regulatory Toxicology and Pharmacology2012;64(Suppl):S35-S44. [DOI: 10.1016/j.yrtph.2012.08.010]">Tricker 2012c</a>). <a href="./references#CD013790-bbs2-0005" title="LüdickeF , PicavetP , BakerG , HazizaC , PouxV , LamaN , et al.Effects of switching to the menthol tobacco heating system 2.2, smoking abstinence, or continued cigarette smoking on clinically relevant risk markers: a randomized, controlled, open-Label, multicenter study in sequential confinement and ambulatory settings (Part 2). Nicotine &amp; Tobacco Research2018;20(2):173-82. [DOI: 10.1093/ntr/ntx028]LüdickeF , PicavetP , BakerG , HazizaC , PouxV , LamaN , et al.Effects of switching to the Tobacco Heating System 2.2 menthol, smoking abstinence, or continued cigarette smoking on biomarkers of exposure: a randomized, controlled, open-label, multicenter study in sequential confinement and ambulatory settings (Part 1). Nicotine &amp; Tobacco Research2018;20(2):161-72. [DOI: 10.1093/ntr/ntw287]NCT01970995.Reduced exposure study using THS 2.2 menthol with 5 days in a confinement setting and 85 days in an ambulatory setting. clinicaltrials.gov/ct2/show/NCT01970995 (first received 28 October 2013). Philip Morris Products SA.Module 7.3.1 of the modified risk tobacco product (MRTP) application from Philip Morris Products S.A. Submission to the U.S. Food &amp; Drug Administration. Study code: 07 REXA07JP2017. ">Lüdicke 2018</a> was at high risk of reporting bias, as one preregistered outcome of interest was not reported (FEV<sub>1</sub>/FVC). </p> </section> <section id="CD013790-sec-0074"> <h4 class="title">Other potential sources of bias</h4> <p>One study was at high risk of other bias as it did not report results across randomised trial arms (<a href="./references#CD013790-bbs2-0008" title="NCT03364751.Effect of switching from cigarette smoking to the use of IQOS on periodontitis treatment outcome. clinicaltrials.gov/ct2/show/NCT03364751 (first received 7 December 2017). ">NCT03364751</a>). Instead, they only reported results based on actual product use. </p> </section> </section> <section id="CD013790-sec-0075"> <h3 class="title" id="CD013790-sec-0075">Effects of interventions</h3> <p>See: <a href="./full#CD013790-tbl-0001"><b>Summary of findings 1</b> Heated tobacco use compared with cigarette smoking</a>; <a href="./full#CD013790-tbl-0002"><b>Summary of findings 2</b> Heated tobacco use compared with abstinence from tobacco</a>; <a href="./full#CD013790-tbl-0003"><b>Summary of findings 3</b> Heated tobacco use compared with snus use</a>; <a href="./full#CD013790-tbl-0004"><b>Summary of findings 4</b> Population‐level impact of heated tobacco on cigarette smoking prevalence</a> </p> <p>See: <a href="./full#CD013790-tbl-0001">summary of findings Table 1</a>: heated tobacco use compared with cigarette smoking; <a href="./full#CD013790-tbl-0002">summary of findings Table 2</a>: heated tobacco use compared with abstinence from tobacco; <a href="./full#CD013790-tbl-0003">summary of findings Table 3</a>: heated tobacco use compared with snus use; <a href="./full#CD013790-tbl-0004">summary of findings Table 4</a>: population‐level impact of heated tobacco on cigarette smoking prevalence. </p> <p>Data on each outcome are summarised below, alongside links to forest plots. In these forest plots, benefit of HTPs is usually shown on the left, as lower toxicant levels or risk of adverse events indicates benefits of HTPs relative to the comparator.  </p> <section id="CD013790-sec-0076"> <h4 class="title">Effectiveness</h4> <section id="CD013790-sec-0077"> <h5 class="title">Tobacco smoking cessation</h5> <p>No studies reported on the effectiveness of heated tobacco for smoking cessation.</p> </section> </section> <section id="CD013790-sec-0078"> <h4 class="title">Safety</h4> <section id="CD013790-sec-0079"> <h5 class="title">Heated tobacco use versus cigarette smoking</h5> <section id="CD013790-sec-0080"> <h6 class="title">Adverse events</h6> <p>Pooled data from six studies showed insufficient evidence of a difference in the number of participants reporting <b>adverse events </b>between those in the heated tobacco use and cigarette smoking groups, but the CI contained the possibility of small but clinically meaningful differences in both directions (RR 1.03, 95% CI 0.92 to 1.15; I<sup>2</sup> = 0%; 1713 participants; <a href="./references#CD013790-fig-0003" title="">Analysis 1.1</a>; <a href="./full#CD013790-tbl-0001">summary of findings Table 1</a>). Two studies were at high risk of bias, while the remaining four were at unclear risk. Removing studies judged at high risk of bias did not substantially change the interpretation of results (RR 0.98, 95% CI 0.87 to 1.11; I<sup>2</sup> = 0%; 1472 participants), neither did removing the two studies that used carbon‐tip, rather than electronic, HTPs (RR 1.04, 95% CI 0.82 to 1.30; I<sup>2</sup> = 35%; 1510 participants). All six studies had a follow‐up of at least four weeks. </p> </section> <section id="CD013790-sec-0081"> <h6 class="title">Serious adverse events</h6> <p>Pooled data from four studies showed insufficient evidence of a difference in <b>serious adverse events</b> reported in the heated tobacco use compared with cigarette smoking group, with a wide CI that contained no difference as well as the possibility of more events in either group (RR 0.79, 95% CI 0.33 to 1.94; I<sup>2</sup> = 0%; 1472 participants; <a href="./references#CD013790-fig-0004" title="">Analysis 1.2</a>; <a href="./full#CD013790-tbl-0001">summary of findings Table 1</a>). All pooled studies were at unclear risk of bias and had a follow‐up of at least four weeks. Removing the two studies that used carbon‐tip, rather than electronic, HTPs did not substantially change the interpretation of results (RR 0.93, 95% CI 0.34 to 2.58; I<sup>2</sup> = 0%; 1269 participants). In a further five studies, there were no serious adverse events reported, which meant their data could not be pooled (<a href="./references#CD013790-bbs2-0004" title="HazizaC , deLa BourdonnayeG , DonelliA , PouxV , SkiadaD , WeitkunatR , et al.Favorable changes in biomarkers of potential harm to reduce the adverse health effects of smoking in smokers switching to the menthol Tobacco Heating System 2.2 for 3 months (Part 2). Nicotine &amp; Tobacco Research2019;22(4):549-59. [DOI: 10.1093/ntr/ntz084]HazizaC , deLa BourdonnayeG , DonelliA , PouxV , SkiadaD , WeitkunatR , et al.Reduction in exposure to selected harmful and potentially harmful constituents approaching those observed upon smoking abstinence in smokers switching to the menthol tobacco heating system 2.2 for 3 months (Part 1). Nicotine &amp; Tobacco Research2019;22(4):539-48. [DOI: 10.1093/ntr/ntz013]NCT01989156.Reduced exposure study using THS 2.2 menthol with 5 days in a confinement setting followed by 86 days in an ambulatory setting. clinicaltrials.gov/ct2/show/NCT01989156 (first received 20 November 2013). Philip Morris Products SA.Module 7.3.1 of the modified risk tobacco product (MRTP) application from Philip Morris Products S.A. Submission to the U.S. Food &amp; Drug Administration. Study code: 08 REXA08US2017. ">Haziza 2019</a>; <a href="./references#CD013790-bbs2-0005" title="LüdickeF , PicavetP , BakerG , HazizaC , PouxV , LamaN , et al.Effects of switching to the menthol tobacco heating system 2.2, smoking abstinence, or continued cigarette smoking on clinically relevant risk markers: a randomized, controlled, open-Label, multicenter study in sequential confinement and ambulatory settings (Part 2). Nicotine &amp; Tobacco Research2018;20(2):173-82. [DOI: 10.1093/ntr/ntx028]LüdickeF , PicavetP , BakerG , HazizaC , PouxV , LamaN , et al.Effects of switching to the Tobacco Heating System 2.2 menthol, smoking abstinence, or continued cigarette smoking on biomarkers of exposure: a randomized, controlled, open-label, multicenter study in sequential confinement and ambulatory settings (Part 1). Nicotine &amp; Tobacco Research2018;20(2):161-72. [DOI: 10.1093/ntr/ntw287]NCT01970995.Reduced exposure study using THS 2.2 menthol with 5 days in a confinement setting and 85 days in an ambulatory setting. clinicaltrials.gov/ct2/show/NCT01970995 (first received 28 October 2013). Philip Morris Products SA.Module 7.3.1 of the modified risk tobacco product (MRTP) application from Philip Morris Products S.A. Submission to the U.S. Food &amp; Drug Administration. Study code: 07 REXA07JP2017. ">Lüdicke 2018</a>; <a href="./references#CD013790-bbs2-0011" title="TrickerAR , JangI , Martin LeroyC , LindnerD , DempseyR .Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 4: eight-day randomized clinical trial in Korea. Regulatory Toxicology and Pharmacology2012;64(Suppl):S45-S53. [DOI: 10.1016/j.yrtph.2012.08.013]">Tricker 2012a</a>; <a href="./references#CD013790-bbs2-0012" title="TrickerAR , KanadaS , TakadaK , Martin LeroyC , LindnerD , SchorpMK , et al.Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 5: 8-day randomized clinical trial in Japan. Regulatory Toxicology and Pharmacology2012;64(Suppl):S54-S63. [DOI: 10.1016/j.yrtph.2012.08.003]">Tricker 2012b</a>; <a href="./references#CD013790-bbs2-0013" title="TrickerAR , StewartAJ , Martin LeroyC , LindnerD , SchorpMK , DempseyR .Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 3: eight-day randomized clinical trial in the UK. Regulatory Toxicology and Pharmacology2012;64(Suppl):S35-S44. [DOI: 10.1016/j.yrtph.2012.08.010]">Tricker 2012c</a>). </p> </section> <section id="CD013790-sec-0082"> <h6 class="title">Secondary outcomes</h6> <section id="CD013790-sec-0083"> <p><b>Toxicant and carcinogen exposure</b></p> <p>Pooled data from 1960 participants across 10 studies showed: </p> <p> <ul id="CD013790-list-0010"> <li> <p>lower <b>1‐OHP</b> at follow‐up in heated tobacco use compared with cigarette smoking groups (LMD −0.42, 95% CI −0.67 to −0.17; <a href="./references#CD013790-fig-0005" title="">Analysis 1.3</a>). Heterogeneity was high at I<sup>2</sup> = 94%, but the direction of the difference was consistent across all studies except <a href="./references#CD013790-bbs2-0009" title="NCT02061917.Switching from usual brand cigarettes to a tobacco-heating cigarette or snus (QoL). clinicaltrials.gov/ct2/show/NCT02061917 (first received 13 February 2014). OgdenM , MaranoKM , JonesBA , MorganWT , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 2. Biomarkers of exposure. Biomarkers2015;20(6-7):391-403. [DOI: 10.3109/1354750X.2015.1094134]OgdenM , MaranoKM , JonesBA , MorganWT , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 3. Biomarkers of biological effect. Biomarkers2015;20(6-7):404-10. [DOI: 10.3109/1354750X.2015.1094135]OgdenM , MaranoKM , JonesBA , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 1. Study design and methodology. Biomarkers2015;20(6-7):382-90. [DOI: 10.3109/1354750X.2015.1094133]">Ogden 2015</a>, where carbon‐tip HTPs were provided. It was also consistent across sensitivity analyses removing two studies at high risk of bias, two studies using carbon‐tip HTPs, and three studies with less than four weeks of follow‐up (<a href="#CD013790-tbl-0005">Table 1</a>); </p> </li> <li> <p>lower <b>3‐HPMA</b> at follow‐up in heated tobacco use compared with cigarette smoking groups (LMD −0.40, 95% CI −0.62 to −0.17; <a href="./references#CD013790-fig-0010" title="">Analysis 1.8</a>). Heterogeneity was high at I<sup>2</sup> = 95%, but the direction of the difference was consistent across sensitivity analyses and all studies except <a href="./references#CD013790-bbs2-0009" title="NCT02061917.Switching from usual brand cigarettes to a tobacco-heating cigarette or snus (QoL). clinicaltrials.gov/ct2/show/NCT02061917 (first received 13 February 2014). OgdenM , MaranoKM , JonesBA , MorganWT , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 2. Biomarkers of exposure. Biomarkers2015;20(6-7):391-403. [DOI: 10.3109/1354750X.2015.1094134]OgdenM , MaranoKM , JonesBA , MorganWT , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 3. Biomarkers of biological effect. Biomarkers2015;20(6-7):404-10. [DOI: 10.3109/1354750X.2015.1094135]OgdenM , MaranoKM , JonesBA , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 1. Study design and methodology. Biomarkers2015;20(6-7):382-90. [DOI: 10.3109/1354750X.2015.1094133]">Ogden 2015</a> (<a href="#CD013790-tbl-0005">Table 1</a>); </p> </li> <li> <p>lower <b>MHBMA</b> at follow‐up in heated tobacco use compared with cigarette smoking groups (LMD −1.15, 95% CI −1.52 to −0.78; <a href="./references#CD013790-fig-0011" title="">Analysis 1.9</a>). Heterogeneity was high at I<sup>2</sup> = 94%, but the direction of the difference was consistent across studies and sensitivity analyses (<a href="#CD013790-tbl-0005">Table 1</a>); </p> </li> <li> <p>lower <b>NNAL</b> at follow‐up in heated tobacco use compared with cigarette smoking groups (LMD −0.81, 95% CI −1.07 to −0.55; <a href="./references#CD013790-fig-0012" title="">Analysis 1.10</a>; <a href="./full#CD013790-tbl-0001">summary of findings Table 1</a>). Heterogeneity was high at I<sup>2</sup> = 92%, but the direction of the difference was consistent across sensitivity analyses and all studies except <a href="./references#CD013790-bbs2-0009" title="NCT02061917.Switching from usual brand cigarettes to a tobacco-heating cigarette or snus (QoL). clinicaltrials.gov/ct2/show/NCT02061917 (first received 13 February 2014). OgdenM , MaranoKM , JonesBA , MorganWT , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 2. Biomarkers of exposure. Biomarkers2015;20(6-7):391-403. [DOI: 10.3109/1354750X.2015.1094134]OgdenM , MaranoKM , JonesBA , MorganWT , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 3. Biomarkers of biological effect. Biomarkers2015;20(6-7):404-10. [DOI: 10.3109/1354750X.2015.1094135]OgdenM , MaranoKM , JonesBA , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 1. Study design and methodology. Biomarkers2015;20(6-7):382-90. [DOI: 10.3109/1354750X.2015.1094133]">Ogden 2015</a> (<a href="#CD013790-tbl-0005">Table 1</a>). Another study also reported NNAL; as data were analysed based on actual product use rather than randomised group, it was not pooled (<a href="./references#CD013790-bbs2-0008" title="NCT03364751.Effect of switching from cigarette smoking to the use of IQOS on periodontitis treatment outcome. clinicaltrials.gov/ct2/show/NCT03364751 (first received 7 December 2017). ">NCT03364751</a>). It found results that were compatible with those from pooled data (LMD −1.46, 95% CI −1.81 to −1.10; 151 participants). </p> </li> </ul> </p> <div class="table" id="CD013790-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Sensitivity analyses for heated tobacco use versus cigarette smoking</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="3" rowspan="1" scope="col" valign=""> <p><b>All data</b> </p> </th> <th align="" class="headercell" colspan="3" rowspan="1" scope="col" valign=""> <p><b>No high risk of bias</b> </p> </th> <th align="" class="headercell" colspan="3" rowspan="1" scope="col" valign=""> <p><b>Only electronic devices</b> </p> </th> <th align="" class="headercell" colspan="3" rowspan="1" scope="col" valign=""> <p><b>≥ 4 weeks' follow‐up</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No. of participants (studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>MD (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>I<sup>2</sup> statistic</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No. of participants (studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>MD (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>I<sup>2</sup> statistic</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No. of participants (studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>MD (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>I<sup>2</sup> statistic</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No. of participants (studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>MD (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>I<sup>2</sup> statistic</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="13" rowspan="1" valign="top"> <p><b>Biomarkers of exposure </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1‐OHP<sup>a</sup>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1960 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.42 (−0.67 to −0.17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1764 (8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.40 (−0.70 to −0.10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1805 (8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.54 (−0.75 to −0.34)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1664 (7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.28 (−0.57 to 0.00)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1‐Naphthol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.60μg/24 hours (−16.11 to 21.31)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.60μg/24 hours (−16.11 to 21.31)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.60μg/24 hours (−16.11 to 21.31)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2‐Naphthol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−4.00μg/24  (−7.89 to −0.11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−4.00μg/24  (−7.89 to −0.11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−4.00μg/24  (−7.89 to −0.11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exhaled CO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1322 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−9.13ppm, (−10.49 to −7.78)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1322 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−9.13ppm, (−10.49 to −7.78)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1322 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−9.13ppm, (−10.49 to −7.78)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1322 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−9.13ppm, (−10.49 to −7.78)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>COHb<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1807 (9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.74 (−0.97 to −0.52)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1611 (7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.76 (−1.07 to −0.44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1659 (7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.84 (−1.07 to −0.60)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1511 (6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.24 (−0.36 to −0.12)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3‐HPMA<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1960 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.40 (−0.62 to −0.17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1764 (8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.34 (−0.59 to −0.09)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1805 (8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.43 (−0.63 to −0.22)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1664 (7)</p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.48 (−0.80 to −0.16)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lead</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cadmium</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MHBMA<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1960 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−1.15 (−1.52 to −0.78)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1764 (8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−1.05 (−1.46 to −0.65)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1805 (8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−1.17 (−1.57 to −0.77)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1664 (7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−1.26 (−1.77 to −0.75)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NNAL<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1959 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.81 (−1.07 to −0.55)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1963 (8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.70 (−0.96 to −0.44)</p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1805 (8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.85 (−1.08 to −0.62)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1663 (7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.80 (−1.16 to −0.44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94%</p> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="13" rowspan="1" valign="top"> <p><b>Biomarkers of harm</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FEV<sub>1</sub><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1290 (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.02 (0.00 to 0.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1095 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.02 (0.01 to 0.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1201 (4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.02 (0.00 to 0.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1290 (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.02 (0.00 to 0.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FVC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>196 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.12 (−0.45 to 0.21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>196 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.12 (−0.45 to 0.21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>196 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.12 (−0.45 to 0.21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FEV<sub>1</sub>/FVC </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systolic blood pressure<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>288 (3)</p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.00 (−0.02 to 0.02)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.01 (−0.02 to 0.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>196 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.01 (−0.04 to 0.02)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>288 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.00 (−0.02 to 0.02)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diastolic blood pressure<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>288 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.00 (−0.03 to 0.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.02 (−0.03 to 0.07)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>196 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.02 (−0.06 to 0.02)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>288 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.00 (−0.03 to 0.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Heart rate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood oxygen saturation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>Difference in means calculated on log‐scale. </p> <p>1‐OHP: 1‐hydroxypyrene; 3‐HPMA: 3‐hydroxypropylmercapturic acid; CI: confidence interval; CO: carbon monoxide; COHb: carboxyhaemoglobin; FEV<sub>1</sub>: forced expiratory volume in one second; FVC: forced vital capacity; MD: mean difference; MHBMA: monohydroxy‐3‐butenyl mercapturic acid; N/A: not available; NNAL: 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanol.  </p> </div> </div> <p>Pooled data for nine studies showed lower levels of <b>COHb</b> at follow‐up in heated tobacco use compared with cigarette smoking groups (LMD −0.74, 95% CI −0.97 to −0.52; 1807 participants; <a href="./references#CD013790-fig-0009" title="">Analysis 1.7</a>; <a href="./full#CD013790-tbl-0001">summary of findings Table 1</a>). Heterogeneity was high at I<sup>2</sup> = 96%, but estimates from each study were consistently in favour of the heated tobacco group. Results were similar after removing two studies at high risk of bias, two studies using carbon‐tip HTPs, and three studies with less than four weeks of follow‐up (<a href="#CD013790-tbl-0005">Table 1</a>). </p> <p>In addition, pooled data from three studies showed lower levels of <b>exhaled CO</b> at follow‐up in heated tobacco use compared with cigarette smoking groups (MD −9.13ppm, 95% CI −10.49 to −7.78; 1322 participants; <a href="./references#CD013790-fig-0008" title="">Analysis 1.6</a>). There was low heterogeneity at I<sup>2</sup> = 4% and effects for each study were in the same direction. All three studies were at unclear risk of bias, used electronic HTPs, and had at least four weeks of follow‐up. </p> <p><a href="./references#CD013790-bbs2-0009" title="NCT02061917.Switching from usual brand cigarettes to a tobacco-heating cigarette or snus (QoL). clinicaltrials.gov/ct2/show/NCT02061917 (first received 13 February 2014). OgdenM , MaranoKM , JonesBA , MorganWT , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 2. Biomarkers of exposure. Biomarkers2015;20(6-7):391-403. [DOI: 10.3109/1354750X.2015.1094134]OgdenM , MaranoKM , JonesBA , MorganWT , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 3. Biomarkers of biological effect. Biomarkers2015;20(6-7):404-10. [DOI: 10.3109/1354750X.2015.1094135]OgdenM , MaranoKM , JonesBA , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 1. Study design and methodology. Biomarkers2015;20(6-7):382-90. [DOI: 10.3109/1354750X.2015.1094133]">Ogden 2015</a> reported data from 63 participants showing insufficient evidence of a difference in <b>1‐naphthol</b> between the heated tobacco use and cigarette smoking groups, with the CI containing the possibility of clinically meaningful effects in either direction (MD 2.60 μg/24 hours, 95% CI −16.11 to 21.31; <a href="./references#CD013790-fig-0006" title="">Analysis 1.4</a>). The study also found that <b>2‐naphthol</b> was lower in the heated tobacco use group compared with the cigarette smoking group; however, the CIs were wide (MD −4.00 μg/24 hours, 95% CI −7.89 to −0.11; <a href="./references#CD013790-fig-0007" title="">Analysis 1.5</a>). This study was at unclear risk of bias, used a carbon‐tip HTP, and had a follow‐up of greater than four weeks.  </p> <p>No studies reported on exposure to <b>lead</b> or <b>cadmium</b>. </p> </section> <section id="CD013790-sec-0084"> <p><b>Biomarkers of harm</b></p> <p>Pooled data from five studies showed greater lung function, measured using<b>FEV<sub>1</sub> </b>, at follow‐up among participants in the heated tobacco use compared with cigarette smoking groups (LMD 0.02, 95% CI 0 to 0.03; I<sup>2</sup> = 0%; 1290 participants; <a href="./references#CD013790-fig-0013" title="">Analysis 1.11</a>). Results were similar after removing two studies at high risk of bias and one study using carbon‐tip HTPs. All five studies had a follow‐up of at least four weeks (<a href="#CD013790-tbl-0005">Table 1</a>). </p> <p>Pooled data from 196 participants across two studies found no evidence of a difference in <b>FVC</b> between those randomised to heated tobacco use versus cigarette smoking, but the CI contained the possibility of clinically meaningful differences in both directions (MD −0.12 L, 95% CI −0.45 to 0.21; I<sup>2</sup> = 38%; <a href="./references#CD013790-fig-0016" title="">Analysis 1.14</a>). Both studies had at least four weeks of follow‐up, were judged at high risk of bias, and provided electronic rather than carbon‐tip devices. </p> <p>Pooled data from 288 participants across three studies showed no evidence of a difference in <b>systolic blood pressure </b>(LMD 0.00, 95% CI −0.02 to 0.02; I<sup>2</sup> = 0%; <a href="./references#CD013790-fig-0014" title="">Analysis 1.12</a>) or <b>diastolic blood pressure</b> (LMD 0.00, 95% CI −0.03 to 0.03; I<sup>2</sup> = 0%; <a href="./references#CD013790-fig-0015" title="">Analysis 1.13</a>) at follow‐up between heated tobacco use and cigarette smoking groups. Results were similar after removing two studies at high risk of bias and one study using carbon‐tip HTPs. All three studies had a follow‐up of at least four weeks (<a href="#CD013790-tbl-0005">Table 1</a>). </p> <p>No studies reported on <b>FEV<sub>1</sub>/FVC</b> , <b>heart rate</b> , or <b>blood oxygen saturation</b>. </p> </section> </section> </section> <section id="CD013790-sec-0085"> <h5 class="title">Heated tobacco use versus abstinence from tobacco </h5> <section id="CD013790-sec-0086"> <h6 class="title">Adverse events</h6> <p>Pooled data from two studies showed insufficient evidence of a difference in the number of participants reporting <b>adverse events</b> between the heated tobacco use and attempted tobacco abstinence groups, with the CI containing the possibility of clinically meaningful differences in both directions (RR 1.12, 95% CI 0.86 to 1.46; I<sup>2</sup> = 0%; 237 participants; <a href="./references#CD013790-fig-0017" title="">Analysis 2.1</a>; <a href="./full#CD013790-tbl-0002">summary of findings Table 2</a>). Both studies were at high risk of bias, used electronic HTPs, and had a follow‐up of at least four weeks. </p> </section> <section id="CD013790-sec-0087"> <h6 class="title">Serious adverse events</h6> <p>Five studies reported that no <b>serious adverse events</b> occurred across either the heated tobacco or tobacco abstinence groups (<a href="./references#CD013790-bbs2-0004" title="HazizaC , deLa BourdonnayeG , DonelliA , PouxV , SkiadaD , WeitkunatR , et al.Favorable changes in biomarkers of potential harm to reduce the adverse health effects of smoking in smokers switching to the menthol Tobacco Heating System 2.2 for 3 months (Part 2). Nicotine &amp; Tobacco Research2019;22(4):549-59. [DOI: 10.1093/ntr/ntz084]HazizaC , deLa BourdonnayeG , DonelliA , PouxV , SkiadaD , WeitkunatR , et al.Reduction in exposure to selected harmful and potentially harmful constituents approaching those observed upon smoking abstinence in smokers switching to the menthol tobacco heating system 2.2 for 3 months (Part 1). Nicotine &amp; Tobacco Research2019;22(4):539-48. [DOI: 10.1093/ntr/ntz013]NCT01989156.Reduced exposure study using THS 2.2 menthol with 5 days in a confinement setting followed by 86 days in an ambulatory setting. clinicaltrials.gov/ct2/show/NCT01989156 (first received 20 November 2013). Philip Morris Products SA.Module 7.3.1 of the modified risk tobacco product (MRTP) application from Philip Morris Products S.A. Submission to the U.S. Food &amp; Drug Administration. Study code: 08 REXA08US2017. ">Haziza 2019</a>; <a href="./references#CD013790-bbs2-0005" title="LüdickeF , PicavetP , BakerG , HazizaC , PouxV , LamaN , et al.Effects of switching to the menthol tobacco heating system 2.2, smoking abstinence, or continued cigarette smoking on clinically relevant risk markers: a randomized, controlled, open-Label, multicenter study in sequential confinement and ambulatory settings (Part 2). Nicotine &amp; Tobacco Research2018;20(2):173-82. [DOI: 10.1093/ntr/ntx028]LüdickeF , PicavetP , BakerG , HazizaC , PouxV , LamaN , et al.Effects of switching to the Tobacco Heating System 2.2 menthol, smoking abstinence, or continued cigarette smoking on biomarkers of exposure: a randomized, controlled, open-label, multicenter study in sequential confinement and ambulatory settings (Part 1). Nicotine &amp; Tobacco Research2018;20(2):161-72. [DOI: 10.1093/ntr/ntw287]NCT01970995.Reduced exposure study using THS 2.2 menthol with 5 days in a confinement setting and 85 days in an ambulatory setting. clinicaltrials.gov/ct2/show/NCT01970995 (first received 28 October 2013). Philip Morris Products SA.Module 7.3.1 of the modified risk tobacco product (MRTP) application from Philip Morris Products S.A. Submission to the U.S. Food &amp; Drug Administration. Study code: 07 REXA07JP2017. ">Lüdicke 2018</a>; <a href="./references#CD013790-bbs2-0011" title="TrickerAR , JangI , Martin LeroyC , LindnerD , DempseyR .Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 4: eight-day randomized clinical trial in Korea. Regulatory Toxicology and Pharmacology2012;64(Suppl):S45-S53. [DOI: 10.1016/j.yrtph.2012.08.013]">Tricker 2012a</a>; <a href="./references#CD013790-bbs2-0012" title="TrickerAR , KanadaS , TakadaK , Martin LeroyC , LindnerD , SchorpMK , et al.Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 5: 8-day randomized clinical trial in Japan. Regulatory Toxicology and Pharmacology2012;64(Suppl):S54-S63. [DOI: 10.1016/j.yrtph.2012.08.003]">Tricker 2012b</a>; <a href="./references#CD013790-bbs2-0013" title="TrickerAR , StewartAJ , Martin LeroyC , LindnerD , SchorpMK , DempseyR .Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 3: eight-day randomized clinical trial in the UK. Regulatory Toxicology and Pharmacology2012;64(Suppl):S35-S44. [DOI: 10.1016/j.yrtph.2012.08.010]">Tricker 2012c</a>), which meant that data could not be pooled (533 participants; <a href="./references#CD013790-fig-0018" title="">Analysis 2.2</a>, <a href="./full#CD013790-tbl-0002">summary of findings Table 2</a>). Two studies were at high risk of bias, while the remaining three were at unclear risk. All studies used electronic HTPs and two had at least four weeks of follow‐up.  </p> </section> <section id="CD013790-sec-0088"> <h6 class="title">Secondary outcomes</h6> <section id="CD013790-sec-0089"> <p><b>Toxicant and carcinogen exposure</b></p> <p>All five studies reporting on biomarkersof toxicant and carcinogen exposure for this comparison used electronic rather than carbon‐tip HTPs. Pooled data from 382 participants across these studies showed:  </p> <p> <ul id="CD013790-list-0011"> <li> <p>higher <b>1‐OHP</b> at follow‐up in heated tobacco use groups compared with tobacco abstinence groups, but CIs were wide and contained no difference (LMD 0.12, 95% CI −0.03 to 0.28; <a href="./references#CD013790-fig-0019" title="">Analysis 2.3</a>). Heterogeneity was moderate with an I<sup>2</sup> of 54%, which reduced to 12% in a sensitivity analysis where the two studies at high risk of bias were removed. The direction of the effect was unchanged after removing these studies and after removing three studies with less than four weeks of follow‐up (<a href="#CD013790-tbl-0006">Table 2</a>); </p> </li> <li> <p>inconsistent results for <b>COHb</b> across subgroups, with I<sup>2</sup> = 77% for subgroup differences. Subgroup results showed higher COHb in heated tobacco use compared with tobacco abstinence groups for intention‐to‐treat analyses (LMD 0.69, 95% CI 0.07 to 1.31; I<sup>2</sup> = 96%; 3 studies, 212 participants; <a href="./references#CD013790-fig-0020" title="">Analysis 2.4</a>), but lower COHb, limited by imprecision, for per‐protocol analyses (LMD −0.32, 95% CI −1.04 to 0.39; I<sup>2</sup> = 91%; 2 studies, 170 participants; <a href="./references#CD013790-fig-0020" title="">Analysis 2.4</a>). Because of these subgroup differences and high overall heterogeneity (I<sup>2</sup> = 99%), we did not present pooled results (<a href="./full#CD013790-tbl-0002">summary of findings Table 2</a>). Heterogeneity was 96% when we removed the two studies at high risk of bias and 91% when we removed the three studies with less than four weeks of follow‐up. The direction of the difference was reversed when studies with less than four weeks of follow‐up were removed (<a href="#CD013790-tbl-0006">Table 2</a>); </p> </li> <li> <p>higher <b>3‐HPMA</b> in heated tobacco use compared with tobacco abstinence groups (LMD 0.56, 95% CI 0.33 to 0.80; <a href="./references#CD013790-fig-0021" title="">Analysis 2.5</a>). Heterogeneity was high with an I<sup>2</sup> of 85%, which reduced to 0% when removing three studies with less than four weeks of follow‐up. Differences were smaller when we removed these studies (LMD 0.35, 95% CI 0.20 to 0.50; 170 participants), but larger when we removed two studies at high risk of bias (LMD 0.64, 95% CI 0.32 to 0.96; 212 participants) (<a href="#CD013790-tbl-0006">Table 2</a>); </p> </li> <li> <p>higher <b>MHBMA</b> in heated tobacco use compared with tobacco abstinence groups (LMD 0.67, 95% CI −0.12 to 1.45; <a href="./references#CD013790-fig-0022" title="">Analysis 2.6</a>), but CIs contained the potential for no difference. Heterogeneity was high with an I<sup>2</sup> of 96%, which reduced to 0% when removing three studies with less than four weeks of follow‐up. Differences were smaller when we removed these studies (LMD 0.07, 95% CI −0.16 to 0.30; 170 participants), but larger when we removed two studies at high risk of bias (LMD 0.97, 95% CI 0.02 to 1.92; 212 participants); </p> </li> <li> <p>higher <b>NNAL</b> in heated tobacco use compared with tobacco abstinence groups (LMD 0.50, 95% CI 0.34 to 0.66; I<sup>2</sup> = 0%; <a href="./references#CD013790-fig-0023" title="">Analysis 2.7</a>; <a href="./full#CD013790-tbl-0002">summary of findings Table 2</a>). Results were similar in sensitivity analyses removing two studies at high risk of bias and three studies with less than four weeks of follow‐up. </p> </li> </ul> </p> <div class="table" id="CD013790-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Sensitivity analyses for heated tobacco use versus abstinence from tobacco</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>All data</b> </p> </th> <th align="" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>No high risk of bias</b> </p> </th> <th align="" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>≥ 4 weeks' follow‐up</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No. of participants (studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>MD (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>I<sup>2</sup> statistic</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No. of participants (studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>MD (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>I<sup>2</sup> statistic</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No. of participants (studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>MD (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>I<sup>2</sup> statistic</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="10" rowspan="1" valign="top"> <p><b>Biomarkers of exposure </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1‐OHP<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>382 (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12 (−0.03 to 0.28)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>212 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.11 (−0.03 to 0.25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.22 (−0.32 to 0.75)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1‐Naphthol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2‐Naphthol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exhaled CO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>COHb<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>382 (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.30 (−0.40 to 1.00)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>212 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.69 (0.07 to 1.31)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.32 (−1.04 to 0.39)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3‐HPMA<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>382 (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.56 (0.33 to 0.80)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>212 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.64 (0.32 to 0.96)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.35 (0.20 to 0.50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lead</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cadmium</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MHBMA<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>382 (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.67 (−0.12 to 1.45)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>212 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.97 (0.02 to 1.92)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.07 (−0.16 to 0.30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NNAL<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>382 (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.50 (0.34 to 0.66)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>212 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.42 (−0.01 to 0.85)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.51 (0.34 to 0.69)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="10" rowspan="1" valign="top"> <p><b>Biomarkers of harm</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FEV<sub>1</sub><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.00 (−0.06 to 0.06)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.00 (−0.06 to 0.06)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FVC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>172 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.02 (−0.29 to 0.26)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>172 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.02 (−0.29 to 0.26)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FEV<sub>1</sub>/FVC </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systolic blood pressure<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170 (2)</p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.02 (−0.01 to 0.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170 (2)</p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.02 (−0.01 to 0.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diastolic blood pressure<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.00 (−0.04 to 0.04)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.00 (−0.04 to 0.04)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Heart rate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood oxygen saturation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>Difference in means calculated on the log‐scale. </p> <p>1‐OHP: 1‐hydroxypyrene; 3‐HPMA: 3‐hydroxypropylmercapturic acid; CI: confidence interval; CO: carbon monoxide; COHb: carboxyhaemoglobin; FEV<sub>1</sub>: forced expiratory volume in one second; FVC: forced vital capacity; MD: mean difference; MHBMA: monohydroxy‐3‐butenyl mercapturic acid; N/A: not available; NNAL: 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanol.  </p> </div> </div> <p>No studies reported on exposure to <b>1‐naphthol</b> , <b>2‐naphthol</b> , <b>exhaled CO</b> , <b>lead</b> , or <b>cadmium</b>. </p> </section> <section id="CD013790-sec-0090"> <p><b>Biomarkers of harm</b></p> <p>Both of the studies that reported on biomarkers of harm were at high risk of bias, used electronic rather than carbon‐tip HTPs, and had at least four weeks of follow‐up. Pooled data from 170 participants across these two studies showed:  </p> <p> <ul id="CD013790-list-0012"> <li> <p>insufficient evidence of a difference in lung function, measured using<b>FEV<sub>1</sub> </b> at follow‐up, among participants in the heated tobacco use compared with tobacco abstinence groups, with the CI including the possibility of clinically meaningful differences in both directions (LMD −0, 95% CI −0.06 to 0.06; I<sup>2</sup> = 38%; <a href="./references#CD013790-fig-0024" title="">Analysis 2.8</a>); </p> </li> <li> <p>higher <b>systolic blood pressure</b> at follow‐up in the heated tobacco use compared with tobacco abstinence groups, but the CI included no difference (LMD 0.02, 95% CI −0.01 to 0.05; I<sup>2</sup> = 0%; <a href="./references#CD013790-fig-0025" title="">Analysis 2.9</a>); </p> </li> <li> <p>insufficient evidence of a difference in <b>diastolic blood pressure</b> at follow‐up between heated tobacco use and tobacco abstinence groups, with the CIs including the possibility of clinically meaningful differences in both directions (LMD 0, 95% CI −0.04 to 0.04; I<sup>2</sup> = 0%; <a href="./references#CD013790-fig-0026" title="">Analysis 2.10</a>). </p> </li> </ul> </p> <p>Both studies also reported data from 172 participants on <b>FVC</b>, with insufficient evidence for a difference between those randomised to use heated tobacco versus tobacco abstinence (MD −0.02 L, 95% CI −0.29 to 0.26;  I<sup>2</sup> = 0%; <a href="./references#CD013790-fig-0027" title="">Analysis 2.11</a>). The CIs contained the possibility of clinically meaningful differences in both directions.  </p> <p>No studies reported <b>FEV<sub>1</sub>/FVC</b> , <b>heart rate</b> , or <b>blood oxygen saturation</b>. </p> </section> </section> </section> <section id="CD013790-sec-0091"> <h5 class="title">Heated tobacco use versus snus use</h5> <section id="CD013790-sec-0092"> <h6 class="title">Adverse events</h6> <p>In <a href="./references#CD013790-bbs2-0009" title="NCT02061917.Switching from usual brand cigarettes to a tobacco-heating cigarette or snus (QoL). clinicaltrials.gov/ct2/show/NCT02061917 (first received 13 February 2014). OgdenM , MaranoKM , JonesBA , MorganWT , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 2. Biomarkers of exposure. Biomarkers2015;20(6-7):391-403. [DOI: 10.3109/1354750X.2015.1094134]OgdenM , MaranoKM , JonesBA , MorganWT , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 3. Biomarkers of biological effect. Biomarkers2015;20(6-7):404-10. [DOI: 10.3109/1354750X.2015.1094135]OgdenM , MaranoKM , JonesBA , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 1. Study design and methodology. Biomarkers2015;20(6-7):382-90. [DOI: 10.3109/1354750X.2015.1094133]">Ogden 2015</a>, a higher number of participants reported <b>adverse events</b> in the group assigned to use heated tobacco compared with snus, but the CI was wide and included no difference (RR 1.30, 95% CI 0.94 to 1.80; 87 participants; <a href="./references#CD013790-fig-0028" title="">Analysis 3.1</a>; <a href="./full#CD013790-tbl-0003">summary of findings Table 3</a>). The study had a follow‐up of at least four weeks, was at unclear risk of bias, and used carbon‐tip HTPs. </p> </section> <section id="CD013790-sec-0093"> <h6 class="title">Serious adverse events</h6> <p><a href="./references#CD013790-bbs2-0009" title="NCT02061917.Switching from usual brand cigarettes to a tobacco-heating cigarette or snus (QoL). clinicaltrials.gov/ct2/show/NCT02061917 (first received 13 February 2014). OgdenM , MaranoKM , JonesBA , MorganWT , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 2. Biomarkers of exposure. Biomarkers2015;20(6-7):391-403. [DOI: 10.3109/1354750X.2015.1094134]OgdenM , MaranoKM , JonesBA , MorganWT , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 3. Biomarkers of biological effect. Biomarkers2015;20(6-7):404-10. [DOI: 10.3109/1354750X.2015.1094135]OgdenM , MaranoKM , JonesBA , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 1. Study design and methodology. Biomarkers2015;20(6-7):382-90. [DOI: 10.3109/1354750X.2015.1094133]">Ogden 2015</a> reported that no <b>serious adverse events</b> occurred across either the heated tobacco or snus use groups (87 participants; <a href="./references#CD013790-fig-0029" title="">Analysis 3.2</a>; <a href="./full#CD013790-tbl-0003">summary of findings Table 3</a>). </p> </section> <section id="CD013790-sec-0094"> <h6 class="title">Secondary outcomes</h6> <section id="CD013790-sec-0095"> <p><b>Toxicant and carcinogen exposure</b></p> <p>Data from 50 participants (52 participants for COHb) in <a href="./references#CD013790-bbs2-0009" title="NCT02061917.Switching from usual brand cigarettes to a tobacco-heating cigarette or snus (QoL). clinicaltrials.gov/ct2/show/NCT02061917 (first received 13 February 2014). OgdenM , MaranoKM , JonesBA , MorganWT , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 2. Biomarkers of exposure. Biomarkers2015;20(6-7):391-403. [DOI: 10.3109/1354750X.2015.1094134]OgdenM , MaranoKM , JonesBA , MorganWT , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 3. Biomarkers of biological effect. Biomarkers2015;20(6-7):404-10. [DOI: 10.3109/1354750X.2015.1094135]OgdenM , MaranoKM , JonesBA , StilesMF .Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 1. Study design and methodology. Biomarkers2015;20(6-7):382-90. [DOI: 10.3109/1354750X.2015.1094133]">Ogden 2015</a> showed: </p> <p> <ul id="CD013790-list-0013"> <li> <p>higher <b>1‐OHP</b> at follow‐up in the heated tobacco compared with snus group (MD 252 μg/24 hours, 95% CI 100 to 404; <a href="./references#CD013790-fig-0030" title="">Analysis 3.3</a>); </p> </li> <li> <p>insufficient  evidence of a difference in <b>1‐naphthol</b> between the heated tobacco and snus groups, but the CI was wide and it contained the possibility of clinically meaningful effects in either direction (MD −2.4 μg/24 hours, 95% CI −27.7 to 22.9; <a href="./references#CD013790-fig-0031" title="">Analysis 3.4</a>); </p> </li> <li> <p>lower <b>2‐naphthol</b> at follow‐up in the heated tobacco compared with snus group, but the CI was wide and contained no difference as well as the possibility of clinically meaningful effects in either direction (MD −3.4 μg/24 hours, 95% CI −10.4 to 3.6; <a href="./references#CD013790-fig-0032" title="">Analysis 3.5</a>); </p> </li> <li> <p>higher <b>COHb</b> at follow‐up in the heated tobacco compared with snus group (MD 2.24% saturation, 95% CI 0.69 to 3.79; <a href="./references#CD013790-fig-0033" title="">Analysis 3.6</a>; <a href="./full#CD013790-tbl-0003">summary of findings Table 3</a>); </p> </li> <li> <p>higher <b>3‐HPMA</b> at follow‐up in the heated tobacco compared with snus group (MD 1.07 mg/24 hours, 95% CI 0.39 to 1.75; <a href="./references#CD013790-fig-0034" title="">Analysis 3.7</a>); </p> </li> <li> <p>insufficient evidence of a difference in <b>MHBMA </b>between the heated tobacco and snus groups, with the CI containing the possibility of clinically meaningful effects in either direction (MD 0.33 μg/24 hours, 95% CI −1.36 to 2.02; <a href="./references#CD013790-fig-0035" title="">Analysis 3.8</a>); </p> </li> <li> <p>lower <b>NNAL</b> at follow‐up in the heated tobacco compared with snus group, but the CI was wide and contained no difference (MD −160 ng/24 hours, 95% CI −339 to 19; <a href="./references#CD013790-fig-0036" title="">Analysis 3.9</a>, <a href="./full#CD013790-tbl-0003">summary of findings Table 3</a>). </p> </li> </ul> </p> <p>No studies reported on exposure to <b>exhaled CO</b> , <b>lead</b> , or <b>cadmium</b>. </p> </section> <section id="CD013790-sec-0096"> <p><b>Biomarkers of harm </b></p> <p>No studies reported on <b>FEV<sub>1</sub> </b> , <b>FVC</b> ,<b>FEV<sub>1</sub>/FVC</b> , <b>systolic blood pressure</b> , <b>diastolic blood pressure</b> , <b>heart rate</b> , or <b>blood oxygen saturation</b>. </p> </section> </section> </section> </section> <section id="CD013790-sec-0097"> <h4 class="title">Smoking prevalence</h4> <section id="CD013790-sec-0098"> <h5 class="title">Cigarette sales</h5> <p><a href="./references#CD013790-bbs2-0002" title="CummingsKM , NahhasGJ , SweanorDT .What is accounting for the rapid decline in cigarette sales in Japan?International Journal of Environmental Research and Public Health2020;17(10):3570. [DOI: 10.3390/ijerph17103570]">Cummings 2020</a> found that the yearly percentage decline in <b>cigarette sales</b> accelerated after the introduction of HTPs in Japan, increasing from a mean decline of −3.10% across 2011–2015 to −16.38% across 2016–2019 (<a href="./full#CD013790-tbl-0004">summary of findings Table 4</a>). This study was considered at serious risk of bias due to the limited number of time points (five) used to calculate the pre‐intervention trend. <a href="./references#CD013790-bbs2-0010" title="StoklosaM , CahnZ , LiberA , NargisN , DropeJ .Effect of IQOS introduction on cigarette sales: evidence of decline and replacement. Tobacco Control2020;29(4):381-7. [DOI: 10.1136/tobaccocontrol-2019-054998]">Stoklosa 2020</a> found similar results using a different method and monthly rather than annual data; it found that per capita cigarette sales were increasing at a rate of 0.10 to 0.14 (depending on statistical approach) per month before the introduction of heated tobacco in Japan. After the introduction, per capita cigarette sales declined at a rate of 0.63 to 0.66 cigarettes per month. This study was at moderate risk of bias, due to possible confounding and lack of a preregistered protocol. However, risk of confounding was partially accounted for using regional controls, with the monthly data enabling a sufficient number of time points used to determine pre‐ and postintervention trends across regions. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD013790-sec-0099" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD013790-sec-0099"></div> <section id="CD013790-sec-0100"> <h3 class="title" id="CD013790-sec-0100">Summary of main results</h3> <p>Our searches found no studies that reported the effectiveness of heated tobacco for smoking cessation, but they did find 11 RCTs assessing the safety of heated tobacco — all of which were funded by tobacco companies. Results on adverse and serious adverse events were inconclusive, with insufficient short‐term evidence of differences between smokers randomised to switch to heated tobacco use or to cigarette smoking, attempted tobacco abstinence, or snus use (<a href="./full#CD013790-tbl-0001">summary of findings Table 1</a>; <a href="./full#CD013790-tbl-0002">summary of findings Table 2</a>; <a href="./full#CD013790-tbl-0003">summary of findings Table 3</a>). No studies detected serious harms considered to be related to heated tobacco use. Pooled data showed there was moderate‐certainty evidence that exposure to some measured toxicants and carcinogens was lower in smokers randomised to switch to heated tobacco than continue smoking cigarettes (<a href="./full#CD013790-tbl-0001">summary of findings Table 1</a>), but very low‐ to moderate‐certainty evidence of higher exposures than in those attempting abstinence from all tobacco (<a href="./full#CD013790-tbl-0002">summary of findings Table 2</a>). </p> <p>No studies directly assessed how trends in smoking prevalence changed following the introduction of heated tobacco to market, but we found two time‐series studies on cigarette sales. Results from both studies showed that the rate of decline in cigarette sales accelerated from before to after the launch of IQOS in Japan (<a href="./full#CD013790-tbl-0004">summary of findings Table 4</a>). However, declining cigarette sales might not translate to falling smoking prevalence, as smokers can reduce the number of cigarettes they smoke without quitting entirely. Moreover, because data were observational, it is possible that changes were caused by other factors (e.g. demographic shifts or delayed effects of tobacco control policies). </p> </section> <section id="CD013790-sec-0101"> <h3 class="title" id="CD013790-sec-0101">Overall completeness and applicability of evidence</h3> <p>Although included studies had conditions in which they asked smokers to switch completely to HTP or attempt abstinence from all tobacco, none reported smoking cessation outcomes. This means that the effectiveness of heated tobacco for smoking cessation remains uncertain. However, we found one ongoing study that will evaluate their effectiveness relative to e‐cigarettes (<a href="./references#CD013790-bbs2-0025" title="CaponnettoP , CarusoM , MagliaM , EmmaR , SaittaD , BusaB , et al.Non-inferiority trial comparing cigarette consumption, adoption rates, acceptability, tolerability, and tobacco harm reduction potential in smokers switching to heated tobacco products or electronic cigarettes: study protocol for a randomized controlled trial. Contemporary Clinical Trials Communications2020;17:100518. [DOI: 10.1016/j.conctc.2020.100518]NCT03569748.Heated tobacco products vs electronic cigarettes. clinicaltrials.gov/ct2/show/NCT03569748 (first received 26 June 2018). ">Caponnetto 2020</a>).   </p> <p>Safety data came from a wide range of locations across Europe, Asia, and North America. Conversely, both time‐series studies used data from a single country (Japan), which limits the generalisability of conclusions. For instance, Japan differs from many countries because it is illegal to sell nicotine e‐cigarettes unless they are registered as a pharmaceutical product. This may have left a gap in the market for heated tobacco. </p> <p>The types of heated tobacco devices produced continues to change over time. While carbon‐tip HTPs such as Eclipse were once the only type available, electronic devices such as IQOS and glo now dominate the market. These products could differ in their safety. It is possible that using newer electronic products, such as those that heat tobacco through induction, could lead to different exposures than those reported here. Therefore, it is important to continue tracking the research into new developments in heated tobacco technology.  </p> <p>All studies on safety that we included were funded by tobacco companies. These companies have a financial incentive to produce results that are favourable towards the products they sell. Data from independent sources are, therefore, needed to confirm the results reported in this review. We cannot rule out the possibility of publication bias.  </p> <p>Safety data came from studies that used optimised settings for switching to exclusive HTP use. Six of the 11 RCTs had an extended period where participants stayed in a clinic, preventing those in the HTP group from easily accessing cigarettes (and vice versa). This means that, while trial data consistently show reduced exposure in people completely substituting HTPs for cigarettes, it remains unclear how exposure changes in people using HTPs in real‐world settings where they have greater access to cigarettes. </p> <p>Serious adverse events were rare as safety data came from studies where participants used heated tobacco for one year at most (median of 13 weeks). Trials with larger samples and longer follow‐up periods are likely needed to establish how switching from cigarettes to heated tobacco affects rates of these events. </p> <p>Biomarker studies assessing exposure to toxicants and carcinogens are only relevant if reducing exposure prevents disease and premature death. Animal studies have shown a dose–response relationship between some exposures, such as nitrosamines, and cancer development, suggesting reduced exposure may indeed reduce disease incidence (<a href="./references#CD013790-bbs2-0043" title="FrankS .Dynamics of Cancer: Incidence, Inheritance, Evolution. Princeton (NJ): Princeton University Press, 2007.">Frank 2007</a>). Nonetheless, longer‐term cohort studies are needed to clarify the impact of switching from cigarettes to heated tobacco. There are several other limitations of biomarker results to consider. First, for biomarkers with an extended half‐life in the body, follow‐up length in some studies may have been too short to accurately estimate the effect of switching from cigarettes to heated tobacco (<a href="./references#CD013790-bbs2-0047" title="GoniewiczML , HavelCM , PengMW , JacobP , DempseyD , YuL , et al.Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol. Cancer Epidemiology, Biomarkers &amp; Prevention2010;18(12):3421. [DOI: 10.1158/1055-9965.EPI-09-0874]">Goniewicz 2010</a>). Second, all comparisons between heated tobacco and abstinence groups came from RCTs using per‐protocol analyses that excluded people who smoked cigarettes. This exclusion may have introduced selection bias without adequately addressing postrandomisation confounding (<a href="./references#CD013790-bbs2-0056" title="HernánMA , RobinsJM .Per-protocol analyses of pragmatic trials. New England Journal of Medicine2017;377:1391-8. [DOI: 10.1056/NEJMsm1605385]">Hernán 2017</a>). Finally, we only reported on biomarkers for a sample of the toxicants and carcinogens present in cigarette smoke or heated tobacco aerosol. Previous reviews found similar reductions in exposure to a broader range of potentially harmful chemicals among those switching from cigarettes to heated tobacco (<a href="./references#CD013790-bbs2-0080" title="SimonaviciusE , McNeillA , ShahabL , BroseLS .Heat-not-burn tobacco products: a systematic literature review. Tobacco Control2018;28(5):582-94. [DOI: 10.1136/tobaccocontrol-2018-054419]">Simonavicius 2018</a>; <a href="./references#CD013790-bbs2-0091" title="ZnykM , JurewiczJ , KaletaD .Exposure to heated tobacco products and adverse health effects, a systematic review. International Journal of Environmental Research and Public Health2021;18(12):6651. [DOI: 10.3390/ijerph18126651]">Znyk 2021</a>). </p> </section> <section id="CD013790-sec-0102"> <h3 class="title" id="CD013790-sec-0102">Quality of the evidence</h3> <p>We considered the certainty of evidence for effectiveness and safety of heated tobacco compared with cigarette smoking, tobacco abstinence, and snus use, along with population‐level data on smoking prevalence and cigarette sales (<a href="./full#CD013790-tbl-0001">summary of findings Table 1</a>; <a href="./full#CD013790-tbl-0002">summary of findings Table 2</a>; <a href="./full#CD013790-tbl-0003">summary of findings Table 3</a>; <a href="./full#CD013790-tbl-0004">summary of findings Table 4</a>).  </p> <p><a href="./full#CD013790-tbl-0001">summary of findings Table 1</a>; <a href="./full#CD013790-tbl-0002">summary of findings Table 2</a>; and <a href="./full#CD013790-tbl-0003">summary of findings Table 3</a> show evidence from RCTs. Reasons for downgrading certainty of evidence included: risk of bias, when most studies pooled were judged at unclear or high risk of bias; imprecision, when confidence intervals were wide and included no difference; inconsistency, when heterogeneity was high and unexplained; and indirectness, when all the studies pooled used carbon‐tip HTPs, which differ substantially from the electronic devices currently on the market.  </p> <section id="CD013790-sec-0103"> <h4 class="title">Effectiveness</h4> <p>We remain uncertain about the effectiveness of HTPs for smoking cessation, as no studies assessed this. </p> </section> <section id="CD013790-sec-0104"> <h4 class="title">Safety</h4> <p>For all comparisons, effect estimates for adverse events or serious adverse events were of low or very‐low certainty, mainly due to imprecision. This means that we remain uncertain about the direction and size of effects. None of the analyses found serious adverse events that were judged to be caused by HTPs or comparators. For the selected biomarker outcomes NNAL and COHb, evidence was moderate certainty when the comparison was with cigarette smoking; moderate or very‐low certainty compared with tobacco abstinence, respectively; and low or very‐low certainty compared with snus use. This means we are more confident about the effects of heated tobacco on biomarkers relative to cigarettes than to tobacco abstinence or snus. </p> </section> <section id="CD013790-sec-0105"> <h4 class="title">Smoking prevalence</h4> <p><a href="./full#CD013790-tbl-0004">summary of findings Table 4</a> shows evidence from time‐series studies investigating smoking prevalence or cigarette sales. We remain uncertain about the impact of rising heated tobacco use on smoking prevalence, as no studies directly assessed this. There was very low‐certainty evidence for an impact on cigarette sales, meaning our confidence in results is limited. We downgraded certainty one level for risk of bias, as the studies were considered at moderate or serious risk of bias. We also downgraded certainty one level for the indirectness of cigarette sales as a proxy for smoking prevalence. This is because falls in cigarette sales do not necessarily translate to reductions in smoking prevalence; people can reduce the number of cigarettes they smoke rather than stopping smoking entirely. </p> </section> </section> <section id="CD013790-sec-0106"> <h3 class="title" id="CD013790-sec-0106">Potential biases in the review process</h3> <p>We took several steps to ensure the review process was robust. We followed standard methods used by the Cochrane Tobacco Addiction Review Group. Our search strategy included a broad range of databases, including the Cochrane Tobacco Addiction Group Specialised Register. We also contacted researchers who have worked on relevant reports by charities or public health bodies to capture studies that we may have otherwise missed. We followed standard Cochrane practice of requiring two review authors to independently screen studies, extract data, and assess risk of bias. None of the authors of this review were also authors of included studies.  </p> </section> <section id="CD013790-sec-0107"> <h3 class="title" id="CD013790-sec-0107">Agreements and disagreements with other studies or reviews</h3> <p>Our results were similar to those from an earlier systematic review by <a href="./references#CD013790-bbs2-0080" title="SimonaviciusE , McNeillA , ShahabL , BroseLS .Heat-not-burn tobacco products: a systematic literature review. Tobacco Control2018;28(5):582-94. [DOI: 10.1136/tobaccocontrol-2018-054419]">Simonavicius 2018</a>, which concluded that HTPs expose "users and bystanders to toxicants, although at substantially lower levels than cigarettes" and noted the lack of studies without links to the tobacco industry. There were analogous results in the Public Health England report into HTPs (<a href="./references#CD013790-bbs2-0070" title="McNeillA , BroseLS , CalderR , BauldL , RobsonD .Evidence review of e-cigarettes and heated tobacco products 2018. Public Health England2018.">McNeill 2018</a>). Our current review differs from these reports because it only uses safety data from RCTs with at least one week of follow‐up. In addition, it includes several studies published between 2018 and 2021 and adds analysis of time‐series studies. </p> <p>One systematic review by <a href="./references#CD013790-bbs2-0065" title="JankowskiM , BrożekGM , LawsonJ , SkoczyńskiS , MajekP , ZejdaJE .New ideas, old problems? Heated tobacco products – a systematic review. International Journal of Occupational Medicine and Environmental Health2019;32(5):595-634. [DOI: 10.13075/ijomeh.1896.01433]">Jankowski 2019</a> examined data from a wide range of study types, including those using animals and cellular models and those examining the chemical composition of heated tobacco aerosol. Because of these less stringent inclusion criteria, their search identified a greater number of studies than our review (97 versus 16). Nonetheless, they found similar results: "in vitro and in vivo assessments of HTP aerosols revealed reduced toxicity, but these were mainly based on studies sponsored by the tobacco industry". They also reported that exposure to toxicants is likely higher in HTP users compared with those not using any tobacco product.  </p> <p>One more recent systematic review by <a href="./references#CD013790-bbs2-0091" title="ZnykM , JurewiczJ , KaletaD .Exposure to heated tobacco products and adverse health effects, a systematic review. International Journal of Environmental Research and Public Health2021;18(12):6651. [DOI: 10.3390/ijerph18126651]">Znyk 2021</a> found that, as we did, there was no evidence on the effectiveness of HTPs for smoking cessation. Their results into the toxicology of HTPs also aligned with ours and with those from the aforementioned reviews. </p> <p>Finally, prior to the US FDA allowing marketing of IQOS as a "reduced exposure" tobacco product in the US, it reviewed evidence into the safety of these products relative to cigarettes  (<a href="./references#CD013790-bbs2-0041" title="US Food and Drug Administration.FDA permits sale of IQOS tobacco heating system through premarket tobacco product application pathway. www.fda.gov/news-events/press-announcements/fda-permits-sale-iqos-tobacco-heating-system-through-premarket-tobacco-product-application-pathway (accessed prior to 21 November 2021).">FDA 2019</a>). This review concluded that "switching completely from conventional cigarettes to the IQOS system significantly reduces your body's exposure to harmful or potentially harmful chemicals" (<a href="./references#CD013790-bbs2-0042" title="US Food and Drug Administration.FDA authorizes marketing of IQOS tobacco heating system with 'reduced exposure' information. www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-iqos-tobacco-heating-system-reduced-exposure-information (accessed prior to 21 November 2021).">FDA 2020</a>). It also emphasised that "the evidence is not sufficient to demonstrate substantiation of either of the claims about reduced risk of tobacco‐related disease or harm". These statements align with our conclusions about the overall completeness of results. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD013790-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-FIG-01" target="_blank"><b></b></a></p> </div><img alt="original image" data-id="CD013790-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/full#CD013790-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-FIG-02" target="_blank"><b></b></a></p> </div><img alt="review authors' judgements about risk of bias domains for each included RCT study. Risk of bias for time‐series studies (Cummings 2020; Stoklosa 2020), assessed using ROBINS‐I tool, are shown in Appendix 3 and Appendix 4. " data-id="CD013790-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>review authors' judgements about risk of bias domains for each included RCT study. Risk of bias for time‐series studies (<a href="./references#CD013790-bbs2-0002" title="CummingsKM , NahhasGJ , SweanorDT .What is accounting for the rapid decline in cigarette sales in Japan?International Journal of Environmental Research and Public Health2020;17(10):3570. [DOI: 10.3390/ijerph17103570]">Cummings 2020</a>; <a href="./references#CD013790-bbs2-0010" title="StoklosaM , CahnZ , LiberA , NargisN , DropeJ .Effect of IQOS introduction on cigarette sales: evidence of decline and replacement. Tobacco Control2020;29(4):381-7. [DOI: 10.1136/tobaccocontrol-2019-054998]">Stoklosa 2020</a>), assessed using ROBINS‐I tool, are shown in <a href="./appendices#CD013790-sec-0116">Appendix 3</a> and <a href="./appendices#CD013790-sec-0117">Appendix 4</a>.  </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/full#CD013790-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Heated tobacco product (HTP) use compared with cigarette smoking, Outcome 1: Adverse events" data-id="CD013790-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Heated tobacco product (HTP) use compared with cigarette smoking, Outcome 1: Adverse events </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Heated tobacco product (HTP) use compared with cigarette smoking, Outcome 2: Serious adverse events" data-id="CD013790-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Heated tobacco product (HTP) use compared with cigarette smoking, Outcome 2: Serious adverse events </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Heated tobacco product (HTP) use compared with cigarette smoking, Outcome 3: 1‐Hydroxypyrene (1‐OHP)" data-id="CD013790-fig-0005" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Heated tobacco product (HTP) use compared with cigarette smoking, Outcome 3: 1‐Hydroxypyrene (1‐OHP) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Heated tobacco product (HTP) use compared with cigarette smoking, Outcome 4: 1‐Naphthol" data-id="CD013790-fig-0006" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Heated tobacco product (HTP) use compared with cigarette smoking, Outcome 4: 1‐Naphthol </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Heated tobacco product (HTP) use compared with cigarette smoking, Outcome 5: 2‐Naphthol" data-id="CD013790-fig-0007" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Heated tobacco product (HTP) use compared with cigarette smoking, Outcome 5: 2‐Naphthol </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Heated tobacco product (HTP) use compared with cigarette smoking, Outcome 6: Exhaled carbon monoxide (CO)" data-id="CD013790-fig-0008" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Heated tobacco product (HTP) use compared with cigarette smoking, Outcome 6: Exhaled carbon monoxide (CO) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Heated tobacco product (HTP) use compared with cigarette smoking, Outcome 7: Carboxyhaemoglobin (COHb)" data-id="CD013790-fig-0009" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Heated tobacco product (HTP) use compared with cigarette smoking, Outcome 7: Carboxyhaemoglobin (COHb) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Heated tobacco product (HTP) use compared with cigarette smoking, Outcome 8: 3‐Hydroxypropylmercapturic acid (3‐HPMA)" data-id="CD013790-fig-0010" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: Heated tobacco product (HTP) use compared with cigarette smoking, Outcome 8: 3‐Hydroxypropylmercapturic acid (3‐HPMA) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Heated tobacco product (HTP) use compared with cigarette smoking, Outcome 9: Monohydroxy‐3‐butenyl mercapturic acid (MHBMA)" data-id="CD013790-fig-0011" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: Heated tobacco product (HTP) use compared with cigarette smoking, Outcome 9: Monohydroxy‐3‐butenyl mercapturic acid (MHBMA) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Heated tobacco product (HTP) use compared with cigarette smoking, Outcome 10: 4‐(Methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanol (NNAL)" data-id="CD013790-fig-0012" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: Heated tobacco product (HTP) use compared with cigarette smoking, Outcome 10: 4‐(Methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanol (NNAL) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Heated tobacco product (HTP) use compared with cigarette smoking, Outcome 11: Forced expiratory volume in 1 second (FEV1)" data-id="CD013790-fig-0013" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: Heated tobacco product (HTP) use compared with cigarette smoking, Outcome 11: Forced expiratory volume in 1 second (FEV<sub>1</sub>) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-001.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Heated tobacco product (HTP) use compared with cigarette smoking, Outcome 12: Systolic blood pressure" data-id="CD013790-fig-0014" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-001.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-001.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1: Heated tobacco product (HTP) use compared with cigarette smoking, Outcome 12: Systolic blood pressure </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-001.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-001.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Heated tobacco product (HTP) use compared with cigarette smoking, Outcome 13: Diastolic blood pressure" data-id="CD013790-fig-0015" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-001.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-001.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1: Heated tobacco product (HTP) use compared with cigarette smoking, Outcome 13: Diastolic blood pressure </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-001.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-001.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Heated tobacco product (HTP) use compared with cigarette smoking, Outcome 14: Forced vital capacity (FVC)" data-id="CD013790-fig-0016" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-001.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-001.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1: Heated tobacco product (HTP) use compared with cigarette smoking, Outcome 14: Forced vital capacity (FVC) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-001.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Heated tobacco product (HTP) use compared with abstinence from tobacco, Outcome 1: Adverse events" data-id="CD013790-fig-0017" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Heated tobacco product (HTP) use compared with abstinence from tobacco, Outcome 1: Adverse events </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Heated tobacco product (HTP) use compared with abstinence from tobacco, Outcome 2: Serious adverse events" data-id="CD013790-fig-0018" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Heated tobacco product (HTP) use compared with abstinence from tobacco, Outcome 2: Serious adverse events </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Heated tobacco product (HTP) use compared with abstinence from tobacco, Outcome 3: 1‐Hydroxypyrene (1‐OHP)" data-id="CD013790-fig-0019" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Heated tobacco product (HTP) use compared with abstinence from tobacco, Outcome 3: 1‐Hydroxypyrene (1‐OHP) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Heated tobacco product (HTP) use compared with abstinence from tobacco, Outcome 4: Carboxyhaemoglobin (COHb)" data-id="CD013790-fig-0020" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Heated tobacco product (HTP) use compared with abstinence from tobacco, Outcome 4: Carboxyhaemoglobin (COHb) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Heated tobacco product (HTP) use compared with abstinence from tobacco, Outcome 5: 3‐Hydroxypropylmercapturic acid (3‐HPMA)" data-id="CD013790-fig-0021" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Heated tobacco product (HTP) use compared with abstinence from tobacco, Outcome 5: 3‐Hydroxypropylmercapturic acid (3‐HPMA) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Heated tobacco product (HTP) use compared with abstinence from tobacco, Outcome 6: Monohydroxy‐3‐butenyl mercapturic acid (MHBMA)" data-id="CD013790-fig-0022" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: Heated tobacco product (HTP) use compared with abstinence from tobacco, Outcome 6: Monohydroxy‐3‐butenyl mercapturic acid (MHBMA) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-002.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Heated tobacco product (HTP) use compared with abstinence from tobacco, Outcome 7: 4‐(Methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanol (NNAL)" data-id="CD013790-fig-0023" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-002.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-002.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2: Heated tobacco product (HTP) use compared with abstinence from tobacco, Outcome 7: 4‐(Methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanol (NNAL) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-002.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-002.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Heated tobacco product (HTP) use compared with abstinence from tobacco, Outcome 8: Forced expiratory volume in 1 second (FEV1)" data-id="CD013790-fig-0024" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-002.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-002.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2: Heated tobacco product (HTP) use compared with abstinence from tobacco, Outcome 8: Forced expiratory volume in 1 second (FEV<sub>1</sub>) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-002.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-002.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Heated tobacco product (HTP) use compared with abstinence from tobacco, Outcome 9: Systolic blood pressure" data-id="CD013790-fig-0025" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-002.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-002.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2: Heated tobacco product (HTP) use compared with abstinence from tobacco, Outcome 9: Systolic blood pressure </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-002.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-002.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Heated tobacco product (HTP) use compared with abstinence from tobacco, Outcome 10: Diastolic blood pressure" data-id="CD013790-fig-0026" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-002.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-002.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2: Heated tobacco product (HTP) use compared with abstinence from tobacco, Outcome 10: Diastolic blood pressure </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-002.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-002.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Heated tobacco product (HTP) use compared with abstinence from tobacco, Outcome 11: Forced vital capacity (FVC)" data-id="CD013790-fig-0027" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-002.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-002.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2: Heated tobacco product (HTP) use compared with abstinence from tobacco, Outcome 11: Forced vital capacity (FVC) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-002.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Heated tobacco product (HTP) use compared with snus use, Outcome 1: Adverse events" data-id="CD013790-fig-0028" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Heated tobacco product (HTP) use compared with snus use, Outcome 1: Adverse events </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Heated tobacco product (HTP) use compared with snus use, Outcome 2: Serious adverse events" data-id="CD013790-fig-0029" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Heated tobacco product (HTP) use compared with snus use, Outcome 2: Serious adverse events </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Heated tobacco product (HTP) use compared with snus use, Outcome 3: 1‐Hydroxypyrene (1‐OHP)" data-id="CD013790-fig-0030" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: Heated tobacco product (HTP) use compared with snus use, Outcome 3: 1‐Hydroxypyrene (1‐OHP) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Heated tobacco product (HTP) use compared with snus use, Outcome 4: 1‐Naphthol" data-id="CD013790-fig-0031" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: Heated tobacco product (HTP) use compared with snus use, Outcome 4: 1‐Naphthol </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-003.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Heated tobacco product (HTP) use compared with snus use, Outcome 5: 2‐Naphthol" data-id="CD013790-fig-0032" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-003.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-003.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3: Heated tobacco product (HTP) use compared with snus use, Outcome 5: 2‐Naphthol </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-003.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-003.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Heated tobacco product (HTP) use compared with snus use, Outcome 6: Carboxyhaemoglobin (COHb)" data-id="CD013790-fig-0033" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-003.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-003.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3: Heated tobacco product (HTP) use compared with snus use, Outcome 6: Carboxyhaemoglobin (COHb) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-003.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-003.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Heated tobacco product (HTP) use compared with snus use, Outcome 7: 3‐Hydroxypropylmercapturic acid (3‐HPMA)" data-id="CD013790-fig-0034" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-003.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-003.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3: Heated tobacco product (HTP) use compared with snus use, Outcome 7: 3‐Hydroxypropylmercapturic acid (3‐HPMA) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-003.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-003.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Heated tobacco product (HTP) use compared with snus use, Outcome 8: Monohydroxy‐3‐butenyl mercapturic acid (MHBMA)" data-id="CD013790-fig-0035" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-003.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-003.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3: Heated tobacco product (HTP) use compared with snus use, Outcome 8: Monohydroxy‐3‐butenyl mercapturic acid (MHBMA) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-003.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013790-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/urn:x-wiley:14651858:media:CD013790:CD013790-CMP-003.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Heated tobacco product (HTP) use compared with snus use, Outcome 9: 4‐(Methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanol (NNAL)" data-id="CD013790-fig-0036" src="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-003.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_t/tCD013790-CMP-003.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3: Heated tobacco product (HTP) use compared with snus use, Outcome 9: 4‐(Methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanol (NNAL) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/media/CDSR/CD013790/image_n/nCD013790-CMP-003.09.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD013790-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Heated tobacco use compared with cigarette smoking</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Heated tobacco use compared with cigarette smoking</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people who smoke<br/><b>Setting:</b> USA, Japan, UK, South Korea, Poland<br/><b>Intervention:</b> heated tobacco use<br/><b>Comparison:</b> cigarette smoking </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with cigarette smoking</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with heated tobacco use</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events</b> – measured by self‐report </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.03</b><br/>(0.92 to 1.15) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1713<br/>(6 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>235 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>242 per 1000<br/>(216 to 270) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Serious adverse events</b> – measured by self‐report and medical records </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.79</b><br/>(0.33 to 1.94) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2009<br/>(9 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>13 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>10 per 1000<br/>(4 to 24) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>NNAL</b><br/>at follow‐up – measured in urine </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>LMD 0.81</b> lower<br/>(1.07 lower to 0.55 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1959<br/>(10 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>LMD has no units as it is calculated from the logarithm of biomarker measurements.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>COHb</b><br/>at follow‐up – measured in blood </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>LMD 0.74</b> lower<br/>(0.92 lower to 0.52 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1807<br/>(9 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>LMD has no units as it is calculated from the logarithm of biomarker measurements.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>COHb:</b> carboxyhaemoglobin; <b>LMD:</b> difference in means of log‐transformed measurements; <b>NNAL:</b> 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanol; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for risk of bias: all studies were at either unclear or high risk of bias.<br/><sup>b</sup>Downgraded one level for imprecision: confidence intervals contain clinically meaningful benefit and clinically meaningful harm.<br/><sup>c</sup>Downgraded two levels for imprecision: confidence intervals contain large clinically meaningful benefit and clinically meaningful harm. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Heated tobacco use compared with cigarette smoking</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/full#CD013790-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD013790-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Heated tobacco use compared with abstinence from tobacco</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Heated tobacco use compared with abstinence from tobacco</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people who smoke<br/><b>Setting:</b> USA, Japan, UK, South Korea<br/><b>Intervention:</b> heated tobacco use<br/><b>Comparison:</b> abstinence from tobacco </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with abstinence from tobacco</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with heated tobacco use</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Smoking cessation</b> – not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events</b> – measured by self‐report </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.12</b><br/>(0.86 to 1.46) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>237<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>468 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>525 per 1000<br/>(403 to 684) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Serious adverse events</b> – measured by self‐report and medical records </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>533<br/>(5 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>c,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No serious adverse events were reported.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>NNAL</b><br/>at follow‐up – measured in urine </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>LMD 0.50</b> higher<br/>(0.34 higher to 0.66 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>382<br/>(5 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>LMD has no units as it is calculated from the logarithm of biomarker measurements.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>COHb</b> at follow‐up – measured in blood </p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p><b>LMD 0.69 higher</b> (0.07 higher to 1.31 higher) for analyses using intention‐to‐treat, but LMD 0.32 lower (1.04 lower to 0.39 higher) for per‐protocol analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>212<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,d,e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reported narratively due to inconsistency of results across subgroups.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>COHb:</b> carboxyhaemoglobin; <b>LMD:</b> difference in means of log‐transformed measurements; <b>NNAL:</b> 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanol; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for imprecision: confidence intervals contained clinically meaningful benefit and clinically meaningful harm.<br/><sup>b</sup>Downgraded two levels for risk of bias: all studies were considered at high risk of bias.<br/><sup>c</sup>Downgraded two levels for imprecision: no serious adverse events occurred so confidence intervals could not be calculated.<br/><sup>d</sup>Downgraded one level for risk of bias: two of the five studies were considered high risk of bias, while three had uncertain risk of bias.<br/><sup>e</sup>Downgraded two levels for inconsistency: there was unexplained heterogeneity and results were inconsistent across subgroups and sensitivity analyses. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Heated tobacco use compared with abstinence from tobacco</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/full#CD013790-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD013790-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Heated tobacco use compared with snus use</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Heated tobacco use compared with snus use</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people who smoke<br/><b>Setting:</b> USA<br/><b>Intervention:</b> heated tobacco use<br/><b>Comparison:</b> snus use </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with snus use</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with heated tobacco use</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Smoking cessation</b> – not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events</b> – measured by self‐report  </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.30</b><br/>(0.94 to 1.80) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>87<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>558 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>726 per 1000<br/>(525 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Serious adverse events</b> – measured by self‐report and medical records </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>44<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No serious adverse events were reported.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>NNAL</b> at follow‐up – measured in urine </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 160 ng/24 hours lower</b><br/>(339 lower to 19 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>COHb</b> at follow‐up – measured in blood </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>6.0% saturation</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3.75% saturation  (2.5% higher to 5.0% higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 2.24% saturation higher</b><br/>(0.69 higher to 3.79 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>COHb:</b> carboxyhaemoglobin; <b>MD:</b> mean difference; <b>NNAL:</b> 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanol; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels for indirectness: participants in the included study were given carbon‐tip heated tobacco products, which are unlike heated tobacco products currently on the market.<br/><sup>b</sup>Downgraded one levels for imprecision: confidence intervals incorporate no clinically meaningful difference.<br/><sup>c</sup>Downgraded two levels for imprecision: no serious adverse events occurred so confidence intervals could not be calculated. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Heated tobacco use compared with snus use</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/full#CD013790-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD013790-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Population‐level impact of heated tobacco on cigarette smoking prevalence</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Population‐level impact of heated tobacco on cigarette smoking prevalence</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Patient or population:</b> N/A<br/><b>Setting:</b> Japan<br/><b>Intervention:</b> introduction of heated tobacco to market<br/><b>Comparison:</b> N/A </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Impact</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cigarette sales</b> – assessed with national and regional sales data </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 study found that the yearly percentage decline in cigarette sales accelerated after the introduction of heated tobacco in Japan, increasing from a mean decline of −3.10% across 2011–2015 to −16.38% across 2016–2019. A second study found similar results using a different method; it found that per capita cigarette sales were increasing at a rate of 0.10 to 0.14 (depending on statistical approach) per month before the introduction of heated tobacco in Japan. After the introduction, they declined at a rate of 0.63 to 0.66 cigarettes per month. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>N/A (2 observational studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>N/A: not applicable/available.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for indirectness: cigarette sales do not necessarily translate to reductions in smoking prevalence, as smokers may reduce the amount they smoke rather than stop smoking entirely.<br/><sup>b</sup>Downgraded one level for risk of bias: one study was considered to be at serious risk of bias, while the other was deemed at moderate risk. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Population‐level impact of heated tobacco on cigarette smoking prevalence</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/full#CD013790-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013790-tbl-0005"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Sensitivity analyses for heated tobacco use versus cigarette smoking</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="3" rowspan="1" scope="col" valign=""> <p><b>All data</b> </p> </th> <th align="" class="headercell" colspan="3" rowspan="1" scope="col" valign=""> <p><b>No high risk of bias</b> </p> </th> <th align="" class="headercell" colspan="3" rowspan="1" scope="col" valign=""> <p><b>Only electronic devices</b> </p> </th> <th align="" class="headercell" colspan="3" rowspan="1" scope="col" valign=""> <p><b>≥ 4 weeks' follow‐up</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No. of participants (studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>MD (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>I<sup>2</sup> statistic</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No. of participants (studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>MD (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>I<sup>2</sup> statistic</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No. of participants (studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>MD (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>I<sup>2</sup> statistic</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No. of participants (studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>MD (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>I<sup>2</sup> statistic</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="13" rowspan="1" valign="top"> <p><b>Biomarkers of exposure </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1‐OHP<sup>a</sup>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1960 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.42 (−0.67 to −0.17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1764 (8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.40 (−0.70 to −0.10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1805 (8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.54 (−0.75 to −0.34)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1664 (7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.28 (−0.57 to 0.00)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1‐Naphthol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.60μg/24 hours (−16.11 to 21.31)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.60μg/24 hours (−16.11 to 21.31)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.60μg/24 hours (−16.11 to 21.31)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2‐Naphthol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−4.00μg/24  (−7.89 to −0.11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−4.00μg/24  (−7.89 to −0.11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−4.00μg/24  (−7.89 to −0.11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exhaled CO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1322 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−9.13ppm, (−10.49 to −7.78)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1322 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−9.13ppm, (−10.49 to −7.78)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1322 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−9.13ppm, (−10.49 to −7.78)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1322 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−9.13ppm, (−10.49 to −7.78)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>COHb<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1807 (9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.74 (−0.97 to −0.52)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1611 (7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.76 (−1.07 to −0.44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1659 (7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.84 (−1.07 to −0.60)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1511 (6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.24 (−0.36 to −0.12)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3‐HPMA<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1960 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.40 (−0.62 to −0.17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1764 (8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.34 (−0.59 to −0.09)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1805 (8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.43 (−0.63 to −0.22)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1664 (7)</p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.48 (−0.80 to −0.16)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lead</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cadmium</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MHBMA<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1960 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−1.15 (−1.52 to −0.78)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1764 (8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−1.05 (−1.46 to −0.65)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1805 (8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−1.17 (−1.57 to −0.77)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1664 (7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−1.26 (−1.77 to −0.75)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NNAL<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1959 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.81 (−1.07 to −0.55)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1963 (8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.70 (−0.96 to −0.44)</p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1805 (8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.85 (−1.08 to −0.62)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1663 (7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.80 (−1.16 to −0.44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94%</p> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="13" rowspan="1" valign="top"> <p><b>Biomarkers of harm</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FEV<sub>1</sub><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1290 (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.02 (0.00 to 0.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1095 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.02 (0.01 to 0.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1201 (4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.02 (0.00 to 0.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1290 (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.02 (0.00 to 0.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FVC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>196 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.12 (−0.45 to 0.21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>196 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.12 (−0.45 to 0.21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>196 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.12 (−0.45 to 0.21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FEV<sub>1</sub>/FVC </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systolic blood pressure<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>288 (3)</p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.00 (−0.02 to 0.02)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.01 (−0.02 to 0.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>196 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.01 (−0.04 to 0.02)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>288 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.00 (−0.02 to 0.02)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diastolic blood pressure<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>288 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.00 (−0.03 to 0.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.02 (−0.03 to 0.07)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>196 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.02 (−0.06 to 0.02)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>288 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.00 (−0.03 to 0.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Heart rate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood oxygen saturation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="13"> <div class="table-footnote"> <p><sup>a</sup>Difference in means calculated on log‐scale. </p> <p>1‐OHP: 1‐hydroxypyrene; 3‐HPMA: 3‐hydroxypropylmercapturic acid; CI: confidence interval; CO: carbon monoxide; COHb: carboxyhaemoglobin; FEV<sub>1</sub>: forced expiratory volume in one second; FVC: forced vital capacity; MD: mean difference; MHBMA: monohydroxy‐3‐butenyl mercapturic acid; N/A: not available; NNAL: 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanol.  </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Sensitivity analyses for heated tobacco use versus cigarette smoking</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/full#CD013790-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013790-tbl-0006"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Sensitivity analyses for heated tobacco use versus abstinence from tobacco</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>All data</b> </p> </th> <th align="" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>No high risk of bias</b> </p> </th> <th align="" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>≥ 4 weeks' follow‐up</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No. of participants (studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>MD (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>I<sup>2</sup> statistic</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No. of participants (studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>MD (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>I<sup>2</sup> statistic</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No. of participants (studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>MD (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>I<sup>2</sup> statistic</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="10" rowspan="1" valign="top"> <p><b>Biomarkers of exposure </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1‐OHP<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>382 (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12 (−0.03 to 0.28)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>212 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.11 (−0.03 to 0.25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.22 (−0.32 to 0.75)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1‐Naphthol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2‐Naphthol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exhaled CO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>COHb<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>382 (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.30 (−0.40 to 1.00)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>212 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.69 (0.07 to 1.31)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.32 (−1.04 to 0.39)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3‐HPMA<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>382 (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.56 (0.33 to 0.80)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>212 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.64 (0.32 to 0.96)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.35 (0.20 to 0.50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lead</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cadmium</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MHBMA<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>382 (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.67 (−0.12 to 1.45)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>212 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.97 (0.02 to 1.92)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.07 (−0.16 to 0.30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NNAL<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>382 (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.50 (0.34 to 0.66)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>212 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.42 (−0.01 to 0.85)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.51 (0.34 to 0.69)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="10" rowspan="1" valign="top"> <p><b>Biomarkers of harm</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FEV<sub>1</sub><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.00 (−0.06 to 0.06)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.00 (−0.06 to 0.06)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FVC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>172 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.02 (−0.29 to 0.26)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>172 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.02 (−0.29 to 0.26)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FEV<sub>1</sub>/FVC </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systolic blood pressure<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170 (2)</p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.02 (−0.01 to 0.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170 (2)</p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.02 (−0.01 to 0.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diastolic blood pressure<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.00 (−0.04 to 0.04)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.00 (−0.04 to 0.04)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Heart rate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood oxygen saturation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p><sup>a</sup>Difference in means calculated on the log‐scale. </p> <p>1‐OHP: 1‐hydroxypyrene; 3‐HPMA: 3‐hydroxypropylmercapturic acid; CI: confidence interval; CO: carbon monoxide; COHb: carboxyhaemoglobin; FEV<sub>1</sub>: forced expiratory volume in one second; FVC: forced vital capacity; MD: mean difference; MHBMA: monohydroxy‐3‐butenyl mercapturic acid; N/A: not available; NNAL: 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanol.  </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Sensitivity analyses for heated tobacco use versus abstinence from tobacco</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/full#CD013790-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013790-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Heated tobacco product (HTP) use compared with cigarette smoking</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1713</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.92, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.33, 1.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 1‐Hydroxypyrene (1‐OHP) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1960</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.42 [‐0.67, ‐0.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 Intention‐to‐treat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.58 [‐0.94, ‐0.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.2 Per‐protocol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>806</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.31 [‐0.68, 0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 1‐Naphthol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 Per‐protocol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 2‐Naphthol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.1 Per‐protocol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Exhaled carbon monoxide (CO) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1322</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.13 [‐10.49, ‐7.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.1 Intention‐to‐treat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>858</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.20 [‐11.01, ‐1.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.2 Per‐protocol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>464</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.37 [‐10.73, ‐8.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Carboxyhaemoglobin (COHb) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1807</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.74 [‐0.97, ‐0.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.1 Intention‐to‐treat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.92 [‐1.44, ‐0.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.2 Per‐protocol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>653</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.61 [‐0.82, ‐0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 3‐Hydroxypropylmercapturic acid (3‐HPMA) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1960</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.40 [‐0.62, ‐0.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.1 Intention‐to‐treat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.19 [‐0.28, ‐0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.2 Per‐protocol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>806</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.53 [‐0.94, ‐0.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Monohydroxy‐3‐butenyl mercapturic acid (MHBMA) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1960</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.15 [‐1.52, ‐0.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.1 Intention‐to‐treat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.75 [‐1.06, ‐0.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.2 Per‐protocol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>806</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.41 [‐1.95, ‐0.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 4‐(Methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanol (NNAL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1959</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.81 [‐1.07, ‐0.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.1 Intention‐to‐treat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.72 [‐1.05, ‐0.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.2 Per‐protocol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>805</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.89 [‐1.32, ‐0.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 Forced expiratory volume in 1 second (FEV<sub>1</sub>) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [0.00, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11.1 Intention‐to‐treat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>858</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [0.00, 0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11.2 Per‐protocol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>432</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.00, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.12 Systolic blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.02, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.1 Per‐protocol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.02, 0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.13 Diastolic blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.03, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.1 Per‐protocol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.03, 0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.14 Forced vital capacity (FVC) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>196</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.12 [‐0.45, 0.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.14.1 Per‐protocol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>196</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.12 [‐0.45, 0.21]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Heated tobacco product (HTP) use compared with cigarette smoking</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013790-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Heated tobacco product (HTP) use compared with abstinence from tobacco</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>237</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.86, 1.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>533</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 1‐Hydroxypyrene (1‐OHP) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>382</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [‐0.03, 0.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.1 Intention‐to‐treat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>212</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [‐0.03, 0.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.2 Per‐protocol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [‐0.32, 0.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Carboxyhaemoglobin (COHb) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.1 Intention‐to‐treat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>212</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.07, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.2 Per‐protocol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.32 [‐1.04, 0.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 3‐Hydroxypropylmercapturic acid (3‐HPMA) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>382</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.33, 0.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.1 Intention‐to‐treat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>212</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.32, 0.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.2 Per‐protocol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.20, 0.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Monohydroxy‐3‐butenyl mercapturic acid (MHBMA) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>382</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [‐0.12, 1.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.1 Intention‐to‐treat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>212</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.02, 1.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.2 Per‐protocol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.16, 0.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.7 4‐(Methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanol (NNAL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>382</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.34, 0.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7.1 Intention‐to‐treat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>212</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.34, 0.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7.2 Per‐protocol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [‐0.01, 0.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.8 Forced expiratory volume in 1 second (FEV<sub>1</sub>) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.06, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.8.1 Per‐protocol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.06, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.9 Systolic blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.01, 0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.1 Per‐protocol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.01, 0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.10 Diastolic blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.04, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.10.1 Per‐protocol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.04, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.11 Forced vital capacity (FVC) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>172</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.29, 0.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.11.1 Per‐protocol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>172</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.29, 0.26]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Heated tobacco product (HTP) use compared with abstinence from tobacco</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013790-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Heated tobacco product (HTP) use compared with snus use</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 1‐Hydroxypyrene (1‐OHP) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 1‐Naphthol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.5 2‐Naphthol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.6 Carboxyhaemoglobin (COHb) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.7 3‐Hydroxypropylmercapturic acid (3‐HPMA) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.8 Monohydroxy‐3‐butenyl mercapturic acid (MHBMA) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.9 4‐(Methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanol (NNAL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Heated tobacco product (HTP) use compared with snus use</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013790.pub2/references#CD013790-tbl-0009">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD013790.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD013790-note-0010">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD013790-note-0019">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD013790-note-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD013790-note-0017">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD013790-note-0015">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD013790-note-0014">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD013790-note-0013">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD013790-note-0018">Polski</a> </li> <li class="section-language"> <a class="" href="th#CD013790-note-0012">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD013790-note-0009">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD013790-note-0011">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013790\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013790\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013790\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013790\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013790\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013790\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013790\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013790\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013790\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013790\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013790\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013790\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013790\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013790\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013790\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013790\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013790\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013790\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=EBp84H4P&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013790.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013790.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD013790.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD013790.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013790.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740728801595"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013790.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740728801599"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013790.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ecd5c3d02f56f',t:'MTc0MDcyODgwMS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 